[{"ID":"14302_30-2021_NCT04795947","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have primary hypothyroidism?\n\nYes, the patient has primary hypothyroidism based on the information provided.\n\n#2: Is the patient's age within the inclusion criteria range (18-75 years old)?\n\nYes, the patient is within the inclusion criteria age range (33 years old).\n\n#3: Has the patient been taking levothyroxine for at least 3 months?\n\nYes, the patient has been taking levothyroxine for at least 3 months.\n\n#4: Are the patient's thyroid function levels within the normal range?\n\nYes, the patient's thyroid function levels (TSH, TT4, FT4, TT3, FT3) are within the normal range.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.923562708},{"ID":"5426_12-2021_NCT03026556","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of non-valvular atrial fibrillation?\n\nYes, the patient has a diagnosis of non-valvular atrial fibrillation (AFIB).\n\n#2: Is the patient treatment naive from all OAC use prior to the first NOAC prescription during the study period?\n\nNo, the patient is not treatment naive from all OAC use prior to the first NOAC prescription during the study period. The patient has a history of taking anticoagulant medications.\n\n#3: Does the patient have at least 12 months of continuous eligibility prior to the index date?\n\nNo, the patient does not have at least 12 months of continuous eligibility prior to the index date. The patient has a history of taking anticoagulant medications, which makes them ineligible for the study.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nC: excluded","PROBA":0.9355785049},{"ID":"35774_75-2021_NCT04308135","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient meet the inclusion criteria for the clinical trial?\n\nThe patient meets the inclusion criteria for the clinical trial because they have been diagnosed with Parkinson's disease and do not have any alternative causes that significantly impair gait.\n\n#3: Does the patient meet any of the exclusion criteria for the clinical trial?\n\nNo, the patient does not meet any of the exclusion criteria for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9340956491},{"ID":"5357_12-2021_NCT02114476","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of gestational diabetes mellitus?\nYes, the patient has a diagnosis of gestational diabetes mellitus.\n\n#2: Does the patient want to use implant contraception or nonhormonal contraceptives such as IUD or tubal sterilization?\nYes, the patient wants to use implant contraception.\n\n#3: Is the patient at least 18 years old?\nYes, the patient is at least 18 years old.\n\n#4: Does the patient have any of the exclusion criteria?\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient would be considered eligible for the study.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9369179921},{"ID":"30621_65-2021_NCT01597232","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a height of usual place of residence less than 2,500 meters above sea level?\n\nNo, the patient does not meet this criterion.\n\n#2: Does the patient have a perioperative hemoglobin level possibly less than 10g\/dL?\n\nYes, the patient's hemoglobin level is 6.5%, which is less than 10g\/dL.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9302983507},{"ID":"6657_15-2021_NCT00991601","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a tumor in the liver or pancreas?\n\nYes, the patient has a tumor in the pancreas.\n\n#2: Is the patient over 18 years old?\n\nYes, the patient is 70 years old.\n\n#3: Does the patient have low coagulation factors?\n\nNo, there is no mention of low coagulation factors in the patient's history.\n\n#4: Is the patient mentally ill?\n\nNo, there is no mention of mental illness in the patient's history.\n\nBased on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.9337414065},{"ID":"17011_36-2021_NCT01250509","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is pre-menopausal (#1), has a BMI of 41.54 (#2), and weighs less than 300 lbs (#3). Therefore, the patient meets all three inclusion criteria.\n\n#2: Does the patient meet any exclusion criteria?\n\nThe patient does not have any of the exclusion criteria listed (#4, #5, #6, #7, #8, #9, #10). Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.8968649066},{"ID":"35828_75-2021_NCT04821830","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease mild to moderate (Hoehn & Yahr Stages I-II)?\nYes, the patient's disease is ranked as mild (Hoehn-Yahr Stage I).\n\n#3: Is the patient about to start treatment with a L-Dopa preparation (Sinemet)?\nNo, the patient is not currently taking any medication for their Parkinson's disease.\n\n#4: Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient would be eligible to participate.","PROBA":0.9336805866},{"ID":"30440_65-2021_NCT00368394","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes mellitus?\nYes, the patient has type 1 diabetes mellitus, which meets the inclusion criterion.\n\n#2: Are there any exclusion criteria that the patient does not meet?\nNo, there are no exclusion criteria listed.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.910801607},{"ID":"5483_12-2021_NCT03768115","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dry eye symptoms that cannot be managed with currently available dry eye medication?\n\nYes, the patient has dry eye symptoms that cannot be managed with currently available dry eye medication. Therefore, the patient meets the first inclusion criterion.\n\n#2: Does the patient have a TBUT of \u226410s?\n\nYes, the patient has a TBUT of \u226410s. Therefore, the patient meets the second inclusion criterion.\n\n#3: Does the patient have presence of corneal fluorescein staining?\n\nYes, the patient has presence of corneal fluorescein staining. Therefore, the patient meets the third inclusion criterion.\n\n#4: Does the patient have visual acuity affected by poor tear film quality?\n\nYes, the patient has visual acuity affected by poor tear film quality. Therefore, the patient meets the fourth inclusion criterion.\n\n#5: Is the patient free of any contraindication for blood extraction\/plasmapheresis?\n\nYes, the patient is free of any contraindication for blood extraction\/plasmapheresis. Therefore, the patient meets the fifth inclusion criterion.\n\n#6: Is the patient between 21 to 99 years old?\n\nYes, the patient is between 21 to 99 years old. Therefore, the patient meets the sixth inclusion criterion.\n\n#7: Does the patient have skin lesions at the site of venepuncture in the antecubital area?\n\nNo, the patient does not have skin lesions at the site of venepuncture in the antecubital area. Therefore, the patient meets the seventh inclusion criterion.\n\nBased on the above assessment, the patient is eligible for the clinical trial.","PROBA":0.9653752165},{"ID":"35439_75-2021_NCT01446276","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have nonalcoholic fatty liver disease (NAFLD)?\n\nNo, the patient does not have NAFLD.\n\n#2: Does the patient have obesity (BMI > 28 kg\/m2, waist\/hip ratio > 0,95)?\n\nYes, the patient has obesity.\n\n#3: Is the patient male?\n\nYes, the patient is male.\n\n#4: Is the patient between 25-65 years old?\n\nYes, the patient is between 25-65 years old.\n\n#5: Does the patient have hypertension and\/or hypercholesterolemia?\n\nYes, the patient has hypertension and\/or hypercholesterolemia.\n\n#6: Does the patient have any other disease than NAFLD (e.g. diabetes, thyroid or parathyroid disease, heart, liver or kidney disease)?\n\nNo, the patient does not have any other disease than NAFLD.\n\n#7: Does the patient have a history of smoking?\n\nNo, the patient does not have a history of smoking.\n\n#8: Has the patient participated in studies with radioactive isotopes within the last six months?\n\nNo, the patient has not participated in studies with radioactive isotopes within the last six months.\n\n#9: Is the patient's hemoglobin within normal range regarding to sex (under 8.3 mmol\/l for men)?\n\nYes, the patient's hemoglobin is within normal range (16.3 mmol\/l).\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9572533345},{"ID":"17092_36-2021_NCT02006368","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because she is not in good health (she has sleep apnea, PCO, and dissatisfaction with her body shape). Therefore, she is not eligible for the clinical trial.\n\nSo, the answer is: B: excluded.","PROBA":0.8218521403},{"ID":"5430_12-2021_NCT03066050","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\nYes, the patient has Marfan's syndrome.\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3: Is the patient planned for mitral valve repair\/replacement surgery?\nYes, the patient is planned for mitral valve repair\/replacement surgery.\n\n#4: Does the patient have a history of gestational diabetes mellitus?\nNo, the patient does not have a history of gestational diabetes mellitus.\n\n#5: Does the patient have hypertension with pregnancy?\nNo, the patient does not have hypertension with pregnancy.\n\n#6: Does the patient have obesity?\nNo, the patient does not have obesity.\n\n#7: Has the patient had previous laser eye surgery, cataract surgery, or foot surgery?\nNo, the patient has not had previous laser eye surgery, cataract surgery, or foot surgery.\n\nBased on the criteria for the clinical trial, the patient is eligible for the study. Therefore, the answer is:\n\nA: eligible","PROBA":0.9444473087},{"ID":"35781_75-2021_NCT04380142","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have idiopathic Parkinson's disease?\n\nNo, the patient does not have idiopathic Parkinson's disease. The patient has a diagnosis of Parkinson's disease, but the word \"idiopathic\" is not mentioned in the patient note. Therefore, the patient does not meet the inclusion criterion of having idiopathic Parkinson's disease.\n\n#2: Is the patient taking a minimum of 400 milligrams\/day of Levodopa (LD) equivalents?\n\nYes, the patient is taking a minimum of 400 milligrams\/day of Levodopa (LD) equivalents. This is mentioned in the patient note as the patient is currently being treated with Levodopa and Trihexyphenidyl. Therefore, the patient meets the inclusion criterion of being taking a minimum of 400 milligrams\/day of Levodopa (LD) equivalents.\n\n#3: Does the patient have a recognizable\/identifiable \"Off\" and \"On\" states (motor fluctuations)?\n\nYes, the patient has a recognizable\/identifiable \"Off\" and \"On\" states (motor fluctuations). The patient note mentions that the patient has slowness of movement and tremors, which are symptoms of Parkinson's disease. The patient also has difficulty entering through a door, which suggests that the patient has motor fluctuations. Therefore, the patient meets the inclusion criterion of having a recognizable\/identifiable \"Off\" and \"On\" states (motor fluctuations).\n\n#4: Does the patient have an average \"Off\" time of at least 2.5 hours\/day over 3 consecutive PD Diary days with a minimum of 2 hours each day?\n\nNo, the patient does not have an average \"Off\" time of at least 2.5 hours\/day over 3 consecutive PD Diary days with a minimum of 2 hours each day. The patient note does not mention the patient's \"Off\" time, so it is unclear whether the patient meets this inclusion criterion.\n\nBased on the information provided, the patient does not meet one of the inclusion criteria (#4) and meets all of the exclusion criteria (#1 and #3), so the patient would be excluded from the clinical trial. Therefore, the answer is B: excluded.","PROBA":0.9446952733},{"ID":"18897_27-2022_NCT02741609","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have early Lyme disease?\n\nNo, the patient does not have early Lyme disease. The patient has a confirmed diagnosis of Lyme disease, but it is not early-stage.\n\n#2: Does the patient have symptoms consistent with late-stage Lyme disease?\n\nYes, the patient has symptoms consistent with late-stage Lyme disease, including a confirmed diagnosis of Lyme disease and a rash.\n\n#3: Has the patient been exposed to antibiotics within the past 6 weeks?\n\nNo, the patient has not been exposed to antibiotics within the past 6 weeks.\n\n#4: Does the patient have an immune deficiency?\n\nNo, the patient does not have an immune deficiency.\n\n#5: Is the patient unwilling or unable to safely have the required quantity of blood drawn for the study?\n\nNo, the patient is willing and able to have the required quantity of blood drawn for the study.\n\n#6: Is the patient unable to understand all of the requirements of the study or unable to give informed consent?\n\nNo, the patient is able to understand all of the requirements of the study and is able to give informed consent.\n\n#7: Has the patient undergone testing for Lyme disease within the past year?\n\nNo, the patient has not undergone testing for Lyme disease within the past year.\n\n#8: Does the patient have a prior diagnosis of Lyme disease?\n\nYes, the patient has a prior diagnosis of Lyme disease.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9495167431},{"ID":"16878_36-2021_NCT00269048","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of cardiovascular disease or risk equivalent?\nNo, the patient does not have a history of cardiovascular disease or risk equivalent. Therefore, this exclusion criterion does not apply.\n\n#2: Is the patient currently taking a stable dose of a statin for at least 4 weeks, with LDL <130 mg\/dL (3.4 mmol\/L) or off statin therapy for at least 4 weeks with LDL <160 mg\/dL (4.1 mmol\/L)?\nNo, the patient is not currently taking a stable dose of a statin. Therefore, this exclusion criterion applies.\n\n#3: Is the patient on a stable dose of at least one oral antiplatelet agent (e.g., aspirin, clopidogrel, or ticlopidine)?\nNo, the patient is not on a stable dose of an oral antiplatelet agent. Therefore, this exclusion criterion applies.\n\nBased on the exclusion criteria, the patient is not eligible for the clinical trial. Therefore, the answer is B: excluded.","PROBA":0.931200672},{"ID":"6891_15-2021_NCT02971475","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have painful chronic pancreatitis?\n\nYes, the patient has abdominal pain that is consistent with chronic pancreatitis.\n\n#2: Does the patient have at least one calcified stone greater than 5 mm in one of its axes in the cephalic or corporeal portion of the main pancreatic duct with upstream duct dilation?\n\nYes, the patient has a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass, which is consistent with a pancreatic stone.\n\n#3: Has the patient had any previous treatments for pancreatitis?\n\nNo, the patient has not had any previous treatments for pancreatitis.\n\n#4: Is the patient's age above 18 years?\n\nYes, the patient is 70 years old, which is above 18 years.\n\n#5: Is the patient pregnant or lactating?\n\nNo, the patient is not pregnant or lactating.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.934878247},{"ID":"17185_36-2021_NCT02726048","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age requirement?\n\nYes, the patient is 32 years old and the study is open to participants aged 18 and older, so the patient meets this criterion.\n\n#2: Is the patient currently using a full-face mask or a nasal mask for NIV therapy?\n\nYes, the patient is currently using a nasal mask for NIV therapy, and the study is open to participants who are existing full-face mask users or nasal mask users, so the patient meets this criterion.\n\n#3: Has the patient been prescribed NIV therapy for at least 3 months?\n\nYes, the patient has been prescribed NIV therapy for at least 3 months, and the study is open to participants who have been prescribed NIV therapy for at least 3 months, so the patient meets this criterion.\n\n#4: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria listed in the study (inability to give informed consent, pregnancy or think they may be pregnant, anatomical or physiological conditions making NIV therapy inappropriate, patients who are in a coma or decreased level of consciousness, existing Simplus and Eson users).\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9377641552},{"ID":"16897_36-2021_NCT00395135","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria for obesity (BMI 30-45 kg\/m2) and at least one obesity-related comorbidity (sleep apnea).\n\n#2: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria for diabetes, pregnancy, or history of heart valve disease.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9204529304},{"ID":"35335_75-2021_NCT00398541","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mild to moderate hypertension?\nYes, the patient has mild hypertension.\n\n#2: Is the patient at least 50 years old?\nYes, the patient is 55 years old, which is greater than 50.\n\n#3: Is the patient literate?\nYes, the patient is literate.\n\n#4: Does the patient have a memory complaint?\nYes, the patient has a memory complaint.\n\n#5: Is the patient taking any cognitive-enhanced agents at baseline?\nNo, the patient is not taking any cognitive-enhanced agents.\n\n#6: Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient is eligible to participate.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9316006935},{"ID":"17397_36-2021_NCT04378101","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a lifetime history of anorexia nervosa, bulimia nervosa, or binge-eating disorder?\n\nNo, the patient does not have a lifetime history of any of these disorders. Therefore, the patient does not meet the inclusion criteria and is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.8986196194},{"ID":"35470_75-2021_NCT01681641","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient eligible and offered treatment with DBS for PD?\nYes, the patient is eligible and has been offered treatment with DBS for PD.\n\n#3: Is the patient married or cohabitant?\nYes, the patient is married.\n\nTherefore, the patient meets all the inclusion criteria and none of the exclusion criteria, so the patient is eligible for the clinical trial.","PROBA":0.9327303679},{"ID":"33719_71-2021_NCT02710786","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have morbid obesity?\n\nYes, the patient has a BMI of 41.5, which is well above the threshold for morbid obesity (BMI \u2265 40). Therefore, the patient meets the inclusion criterion of having morbid obesity.\n\n#2: Has the patient had gastric bypass surgery?\n\nYes, the patient has had gastric bypass surgery, as indicated in the patient note. Therefore, the patient meets the inclusion criterion of having had gastric bypass surgery.\n\n#3: Is the patient registered in the Scandinavian Obesity Surgery Registry (SOReg)?\n\nNo, the patient note does not mention registration in the SOReg. Therefore, the patient does not meet the inclusion criterion of being registered in the SOReg.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the inclusion criterion of being registered in the SOReg. Therefore, the answer is:\n\nB: excluded","PROBA":0.9288620796},{"ID":"13931_30-2021_NCT00150111","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Graves' disease?\n\nYes, the patient has been diagnosed with Graves' disease based on the symptoms and laboratory results.\n\n#2: Is the patient female?\n\nYes, the patient is a female.\n\n#3: Is the patient of childbearing potential?\n\nNo, the patient is not of childbearing potential (she is postmenopausal).\n\n#4: Has the patient received previous rituximab treatment?\n\nNo, the patient has not received previous rituximab treatment.\n\n#5: Does the patient have any serious concomitant diseases?\n\nNo, the patient does not have any serious concomitant diseases.\n\n#6: Does the patient have active infections?\n\nNo, the patient does not have any active infections.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9280998615},{"ID":"17187_36-2021_NCT02733744","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the age range of 18-65 years for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Gender\nThe patient is a woman, which is within the gender inclusion criterion of \"Men or women \u2265 18 and \u2264 65 years old\". Therefore, the patient meets the gender inclusion criterion.\n\n#3: Medical history\nThe patient has a medical history of obesity, sleep apnea, PCO, and dissatisfaction with her body shape. However, these conditions are not explicitly listed as exclusion criteria in the clinical trial. Therefore, the patient meets the inclusion criterion for medical history.\n\n#4: Current health status\nThe patient has a BMI of 41.54, which is within the range of 18.5-30 for the clinical trial. She also has a high heart rate of 195\/min, which is within the range of 100-140 beats per minute for the clinical trial. Additionally, her lab results are within the normal range. Therefore, the patient meets the inclusion criterion for current health status.\n\n#5: Other criteria\nThe patient is willing to undergo fecal microbiota transplantation (FMT) and has given informed consent. She is also able to swallow oral medications, which is an inclusion criterion. Therefore, the patient meets all the inclusion criteria for the clinical trial.\n\nBased on the above analysis, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nC: irrelevant","PROBA":0.9037130054},{"ID":"23212_33-2022_NCT01145612","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have Marfan syndrome?\n\nNo, the patient does not have Marfan syndrome.\n\n#2: Is the patient male or female, aged between 5 and 60 years?\n\nYes, the patient is male and is aged between 5 and 60 years.\n\n#3: Is the patient able to take oral medication?\n\nYes, the patient is able to take oral medication.\n\n#4: Is the patient willing to avoid pregnancy if female, or is the patient surgically sterile or post-menopausal for at least two years?\n\nNo, the patient is not female and therefore does not need to avoid pregnancy.\n\n#5: Does the patient have a maximum diameter of the aorta, at length, <45 mm?\n\nNo, the patient does not have a maximum diameter of the aorta, at length, <45 mm.\n\n#6: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.942838803},{"ID":"23402_33-2022_NCT02545686","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a cancer diagnosis?\nNo, the patient does not have a cancer diagnosis. Therefore, the patient meets the inclusion criterion of \"Normal volunteers without a cancer diagnosis.\"\n\n#2: Does the patient have any contraindications to the use of CPAP?\nNo, the patient does not have any contraindications to the use of CPAP. Therefore, the patient meets the inclusion criterion of \"No contraindications to the use of CPAP.\"\n\n#3: Does the patient have any facial injury or deformity preventing wearing a facial mask?\nNo, the patient does not have any facial injury or deformity preventing wearing a facial mask. Therefore, the patient meets the inclusion criterion of \"No facial injury or deformity preventing wearing facial mask.\"\n\n#4: Does the patient have any recurrent vomiting or chronic cough with phlegm?\nNo, the patient does not have any recurrent vomiting or chronic cough with phlegm. Therefore, the patient meets the inclusion criterion of \"No recurrent vomiting or chronic cough with phlegm.\"\n\n#5: Does the patient have any previous pneumothorax?\nNo, the patient does not have any previous pneumothorax. Therefore, the patient meets the inclusion criterion of \"No previous pneumothorax.\"\n\n#6: Does the patient have any facial lacerations or fractures?\nNo, the patient does not have any facial lacerations or fractures. Therefore, the patient meets the inclusion criterion of \"No facial lacerations or fractures.\"\n\n#7: Has the patient had any recent tracheal or esophageal anastomosis?\nNo, the patient has not had any recent tracheal or esophageal anastomosis. Therefore, the patient meets the inclusion criterion of \"No recent tracheal or esophageal anastomosis.\"\n\n#8: Has the patient had any recent GI surgery (within the last 90 days)?\nNo, the patient has not had any recent GI surgery (within the last 90 days). Therefore, the patient meets the inclusion criterion of \"No recent GI surgery.\"\n\n#9: Is the patient between the ages of 18 and 90?\nYes, the patient is between the ages of 18 and 90. Therefore, the patient meets the inclusion criterion of \"18-90 years of age.\"\n\n#10: Can the patient sign informed consent?\nYes, the patient can sign informed consent. Therefore, the patient meets the inclusion criterion of \"Ability to sign informed consent.\"\n\nSince the patient meets all of the inclusion criteria and none of the exclusion criteria, the patient is eligible for the clinical trial. Therefore, the patient is \"eligible\" for the clinical trial.","PROBA":0.9754564896},{"ID":"27701_40-2022_NCT02001324","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have abnormal uterine bleeding?\nYes, the patient has prolonged oral bleeding after a tooth extraction, which is a form of abnormal uterine bleeding.\n\n#2: Is the patient between the ages of 18 and 51 years?\nYes, the patient is 23 years old, which is within the age range of 18 to 51 years.\n\n#3: Does the patient have an intact uterus?\nNo, the patient had a tooth extraction, which suggests that she does not have an intact uterus.\n\n#4: Can the patient read and write in English?\nYes, the patient can read and write in English.\n\nBased on the criteria for the clinical trial, the patient is not eligible because she does not have an intact uterus. Therefore, the answer is B: excluded.","PROBA":0.9224637332},{"ID":"17046_36-2021_NCT01622257","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have PCOS?\n\nYes, the patient has PCOS, so we can proceed to the next criterion.\n\n#2: Is the patient obese?\n\nYes, the patient is obese, so we can proceed to the next criterion.\n\n#3: Is the patient infertile?\n\nNo, the patient is not infertile, so the patient does not meet the inclusion criteria for the clinical trial.\n\nTherefore, the patient is not eligible for the clinical trial.\n\n\n\n\n\n\n","PROBA":0.8902158308},{"ID":"17246_36-2021_NCT03193047","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the age range of 18-65 years for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Fasting LDL-C\nThe patient's fasting LDL-C is 113 mg\/dL, which is above the inclusion criterion of \u2265160 mg\/dL. Therefore, the patient meets the inclusion criterion for fasting LDL-C.\n\n#3: PCSK9i Therapy\nThe patient is currently receiving PCSK9 inhibitor therapy, which meets the inclusion criterion of following PCSK9i therapy \u226570 mg\/dL.\n\n#4: Other Inclusion Criteria\nThe patient does not have any of the exclusion criteria, such as heterozygous or homozygous familial hypercholesterolemia, uncontrolled hypertension, uncontrolled hypothyroidism, liver disease or dysfunction, gastrointestinal conditions or procedures, history of hematologic or coagulation disorders, or history of malignancy.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9347953353},{"ID":"25322_53-2021_NCT03504280","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypovitaminosis D?\n\nYes, the patient has hypovitaminosis D because her serum 25 OH D level is < 20 ng\/ml.\n\n#2: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9066464994},{"ID":"14147_30-2021_NCT03082807","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of regular exercise in the last three months?\n\nNo, the patient does not have a history of regular exercise in the last three months. Therefore, the patient does not meet the inclusion criteria.\n\n#2: Does the patient have any history of CVD or other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals?\n\nNo, the patient does not have any of these conditions. Therefore, the patient does not meet the exclusion criteria.\n\n#3: Does the patient have abnormality in thyroid or Electrocardiograph?\n\nNo, the patient does not have any abnormality in thyroid or Electrocardiograph. Therefore, the patient does not meet the exclusion criteria.\n\n#4: Has the patient ever taken any anti-obesity medication or weight loss drugs or dietary supplementations for weight control?\n\nNo, the patient has not taken any anti-obesity medication or weight loss drugs or dietary supplementations for weight control. Therefore, the patient does not meet the exclusion criteria.\n\nBased on the above, the patient is not eligible for the clinical trial.","PROBA":0.9475509353},{"ID":"5538_12-2021_NCT04402931","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\n\nThe patient is 34 years old, which is less than 70 years old, the upper age limit for inclusion in the clinical trial. Therefore, the patient meets the age criterion for inclusion.\n\n#2: Symptoms of heart failure\n\nThe patient has symptoms of heart failure, with New York Heart Association (NYHA) class III and IV, which meets the criterion for inclusion.\n\n#3: Severe mitral bioprosthetic dysfunction\n\nThe patient has severe mitral bioprosthetic dysfunction, as evidenced by echocardiography, which meets the criterion for inclusion.\n\n#4: Heart team assessment\n\nThe heart team, including a cardiac surgeon, has assessed the patient as being eligible for the study, which meets the criterion for inclusion.\n\n#5: No contraindications to transcatheter valve-in-valve implantation\n\nThe patient does not have any contraindications to transcatheter valve-in-valve implantation, such as hostile chest or active bacterial endocarditis, which meets the criterion for inclusion.\n\nTherefore, based on the criteria provided, the patient is eligible for the clinical trial.","PROBA":0.9350801884},{"ID":"28027_40-2022_NCT04157309","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a female between the ages of 18-30, which meets the first inclusion criterion.\n\n#2: Does the patient have heavy menstrual cycles?\n\nYes, the patient has heavy menstrual cycles each month, which meets the second inclusion criterion.\n\n#3: Does the patient have any medical problems that might influence the results of the study?\n\nNo, the patient does not have any medical problems that might influence the results of the study, which meets the third inclusion criterion.\n\n#4: Is the patient willing to avoid alcohol, unapproved medications, marijuana products, and illicit substances for 3 days prior to each urine collection?\n\nNo, the patient is not willing to avoid these substances, which violates the fourth inclusion criterion.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9314652894},{"ID":"35659_75-2021_NCT03523104","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient have a positive LRRK2 variant?\n\nNo, the patient does not have a positive LRRK2 variant.\n\nBased on the criteria provided, the patient is not eligible for the clinical trial. Therefore, the answer is \"B: excluded\".","PROBA":0.8988501589},{"ID":"35450_75-2021_NCT01506791","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a healthy, normal adult man or woman who volunteers to participate?\n\nYes, the patient is a healthy, normal adult man who volunteers to participate.\n\n#2: Is s\/he within 18 to 45 years of age, inclusive?\n\nNo, the patient is 55 years old, which is outside the age range of 18 to 45 years.\n\n#3: Is his\/her BMI between 19 and 30 inclusive?\n\nNo, the patient's BMI is not between 19 and 30.\n\n#4: Is she willing to avoid pregnancy by abstaining from sexual intercourse with a non-sterile male partner, or by the use one of the following methods: diaphragm + spermicide or condom + spermicide (at least 14 days before dosing), intra-uterine contraceptive device or hormonal contraceptives (at least 4 week prior to dosing) or has she been surgically sterile or post-menopausal at least six months prior to entering into the study?\n\nYes, the patient is willing to avoid pregnancy by abstaining from sexual intercourse.\n\n#5: Is s\/he considered reliable and capable of understanding his\/her responsibility and role in the study?\n\nYes, the patient is considered reliable and capable of understanding his\/her responsibility and role in the study.\n\n#6: Has s\/he provided written informed consent?\n\nYes, the patient has provided written informed consent.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9698245223},{"ID":"17234_36-2021_NCT03100292","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI \u2265 35 kg\/m2 or BMI \u2265 30 kg\/m2 with co-morbidities such as hypertension, glucose intolerance, dyslipidemia, and sleep apnea?\n\nNo, the patient does not meet this criterion. Her BMI is 41.54, which is well above the threshold of 35 kg\/m2, but she does not have any of the co-morbidities listed.\n\n#2: Is the patient suitable for general anesthesia?\n\nYes, the patient is suitable for general anesthesia.\n\n#3: Is the patient able to give informed consent and committed to follow-up?\n\nYes, the patient is able to give informed consent and committed to follow-up.\n\n#4: Is the patient a female who has a negative urine pregnancy test at screening and agrees to use a reliable method of contraception for 1 year?\n\nNo, the patient is a male.\n\n#5: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient would be eligible to participate.","PROBA":0.9357766001},{"ID":"35337_75-2021_NCT00430755","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is an inpatient in a hospital environment, so they meet the inclusion criteria.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not have any signs of inability to give an informed consent, so they do not meet the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9132949354},{"ID":"14021_30-2021_NCT01486667","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have subclinical hypothyroidism?\n\nYes, the patient has subclinical hypothyroidism, as defined by a serum TSH concentration above 5.0 IU\/mL when serum FT4 level is within the reference range.\n\n#2: Does the patient have OSA?\n\nYes, the patient has OSA, as defined by an Apnea Hypopnea Index (AHI) score of 5 to 15\/h.\n\n#3: Is the patient taking Levothyroxine or lipid-lowering medications?\n\nNo, the patient is not taking Levothyroxine or lipid-lowering medications.\n\n#4: Does the patient have any conditions known to cause dyslipidemia?\n\nNo, the patient does not have any conditions known to cause dyslipidemia, such as uncontrolled diabetes mellitus or alcoholism.\n\n#5: Does the patient have any conditions indicating levothyroxine treatment?\n\nNo, the patient does not have any conditions indicating levothyroxine treatment, such as TSH levels more than 10 mU\/l or clear symptoms or signs associated with thyroid failure.\n\n#6: Is the patient pregnant, breastfeeding, or allergic to levothyroxine?\n\nNo, the patient is not pregnant, breastfeeding, or allergic to levothyroxine.\n\nTherefore, based on the criteria provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9648544285},{"ID":"6604_15-2021_NCT00424827","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have histological confirmation of pancreatic adenocarcinoma?\n\nYes, the patient has a history of pancreatic adenocarcinoma.\n\n#2: Is the patient's disease unresectable and non-metastatic?\n\nYes, the patient has unresectable, non-metastatic disease.\n\n#3: Has the patient undergone endoscopic ultrasound and either laparotomy or laparoscopy within 42 days of registration?\n\nNo, the patient has not undergone endoscopic ultrasound and either laparotomy or laparoscopy within 42 days of registration.\n\n#4: Does the patient have measurable or evaluable disease?\n\nYes, the patient has measurable disease (a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass).\n\n#5: Is the patient willing and able to swallow medication?\n\nYes, the patient is able to swallow medication.\n\nBased on the criteria above, the patient is eligible for the clinical trial.","PROBA":0.9352701476},{"ID":"30600_65-2021_NCT01512654","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 25 years old, which is within the inclusion criteria age range of 18 to 70 years old. Therefore, the patient meets the age criterion.\n\n#2: Diabetes diagnosis\nThe patient has been diagnosed with type 1 diabetes for at least one year prior to study entry, which meets the inclusion criterion of being diagnosed with type 1 or type 2 diabetes.\n\n#3: Insulin therapy\nThe patient is treated by basal-bolus insulin therapy using an external pump or multiple-daily injections, which meets the inclusion criterion of being treated by a basal-bolus insulin therapy.\n\n#4: HbA1c level\nThe patient's HbA1c level is between 7.5% and 10.5%, which meets the inclusion criterion of having a stable diabetes with a HbA1c between \u2265 7.5 % and < 10.5 % with no keto-acidosis for the previous 6 months.\n\n#5: BMI\nThe patient's BMI is lower than 35 Kg\/m\u00b2, which meets the inclusion criterion of having a BMI lower than 35 Kg\/m\u00b2.\n\n#6: Willingness to undergo procedures\nThe patient must be willing to undergo all study procedures, which is not explicitly stated as an inclusion criterion but is implied by the fact that the patient is participating in the clinical trial.\n\n#7: Affiliation with social medical insurance\nThe patient must be affiliated or beneficiary of a social medical insurance, which is not explicitly stated as an inclusion criterion but is implied by the fact that the patient is participating in the clinical trial.\n\n#8: Signed informed consent form\nThe patient must have signed an informed consent form prior to study entry, which is not explicitly stated as an inclusion criterion but is implied by the fact that the patient is participating in the clinical trial.\n\nTherefore, the patient meets all the inclusion criteria for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9493529649},{"ID":"6844_15-2021_NCT02555735","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have histological or cytological confirmation of pancreatic adenocarcinoma?\n\nYes, the patient has a histological confirmation of pancreatic adenocarcinoma based on the biopsy results.\n\n#2: Is the patient treatment-naive or currently receiving chemotherapy?\n\nThe patient is currently receiving chemotherapy, so they meet this inclusion criterion.\n\n#3: Does the patient have an ECOG performance status of 0-2?\n\nThe patient's ECOG performance status is 2, which is above the inclusion criterion of 0-2.\n\n#4: Is the patient's hemoglobin level 7.5 g\/dl or greater and are they hemodynamically stable and\/or physiologically compensated for their anemia?\n\nThe patient's hemoglobin level is 7.5 g\/dl, which meets the inclusion criterion. However, the patient's anemia is not well-compensated, as they have a low HCT level (30.7%) and are receiving IV antibiotics for a suspected abscess.\n\nBased on the above criteria, the patient is not eligible for the clinical trial due to their ECOG performance status (2) and the fact that they are not well-compensated for their anemia.","PROBA":0.9182450675},{"ID":"11652_17-2022_NCT01927536","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have normal vision?\nNo, the patient has slowly worsening vision in both eyes. Therefore, the patient does not meet the inclusion criterion of normal vision.\n\n#2: Is the patient between 18 and 65 years old?\nYes, the patient is 67 years old, which is within the inclusion criteria of 18-65 years old.\n\n#3: Is the patient not colorblind?\nYes, the patient does not have colorblindness.\n\n#4: Is the patient not pregnant?\nYes, the patient is not pregnant.\n\n#5: Is the patient not a prisoner?\nYes, the patient is not a prisoner.\n\n#6: Is the patient not decisionally challenged?\nYes, the patient is not decisionally challenged.\n\nBased on the criteria, the patient is not eligible for the clinical trial. Therefore, the answer is B: excluded.","PROBA":0.9314150524},{"ID":"27593_40-2022_NCT01124357","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have heavy menstrual bleeding without organic pathology (DUB) of more than six months duration?\n\nYes, the patient has heavy menstrual bleeding that has persisted for more than six months. Therefore, this criterion is met.\n\n#2: Is the patient premenopausal with a follicular follicle stimulating hormone (FSH) level of less than 40 IU\/L?\n\nYes, the patient is premenopausal and has a follicular FSH level of less than 40 IU\/L. Therefore, this criterion is met.\n\n#3: Does the patient have associated functional disability (negative impact on life quality)?\n\nYes, the patient has experienced functional disability due to the heavy menstrual bleeding, which has had a negative impact on her life quality. Therefore, this criterion is met.\n\n#4: Has the patient failed to respond to medical treatment?\n\nYes, the patient has failed to respond to medical treatment for her heavy menstrual bleeding. Therefore, this criterion is met.\n\n#5: Is the patient prepared to undergo surgical treatment without general anaesthesia?\n\nYes, the patient is prepared to undergo surgical treatment without general anaesthesia. Therefore, this criterion is met.\n\nBased on the criteria listed above, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9373831848},{"ID":"17436_36-2021_NCT04701034","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a body mass index (BMI) of 35 or greater?\n\nNo, the patient's BMI is not 35 or greater. Therefore, this is not an exclusion criterion.\n\n#2: Is the patient 41 years of age or older?\n\nNo, the patient is 32 years old, which is less than 41. Therefore, this is not an exclusion criterion.\n\n#3: Does the patient have a significant uterine malformation(s)?\n\nNo, there is no mention of any uterine malformations in the patient's information. Therefore, this is not an exclusion criterion.\n\n#4: Does the patient have a known parental balanced chromosomal translocation?\n\nNo, there is no mention of any chromosomal translocations in the patient's information. Therefore, this is not an exclusion criterion.\n\n#5: Has the patient had \u22652 previous pregnancies with fetuses having known abnormal karyotype?\n\nNo, there is no mention of any previous pregnancies or karyotype information in the patient's information. Therefore, this is not an exclusion criterion.\n\n#6: Is the patient taking any medications interacting with prednisolone?\n\nNo, there is no mention of any medications that the patient is taking that would interact with prednisolone. Therefore, this is not an exclusion criterion.\n\n#7: Does the patient have moderate\/severe hypertension, diabetes mellitus, heart insufficiency, severe mental disorders, Cushing syndrome, myasthenia gravis, ocular herpes simplex, pheochromocytoma, systemic sclerosis, or moderate\/severe renal dysfunction?\n\nNo, there is no mention of any of these conditions in the patient's information. Therefore, this is not an exclusion criterion.\n\n#8: Does the patient have a clinical or biochemical profile indicating need for heparin or levothyroxine treatment during pregnancy?\n\nNo, there is no mention of any need for heparin or levothyroxine treatment during pregnancy in the patient's information. Therefore, this is not an exclusion criterion.\n\n#9: Has the patient previously received IVIg?\n\nNo, there is no mention of any previous receipt of IVIg in the patient's information. Therefore, this is not an exclusion criterion.\n\n#10: Does the patient have an allergy to prednisolone and\/or IVIg?\n\nNo, there is no mention of any allergies to prednisolone and\/or IVIg in the patient's information. Therefore, this is not an exclusion criterion.\n\n#11: Does the patient have a low anti-M\u00fcllerian hormone (AMH) level (<4 pmol\/L)?\n\nYes, the patient's AMH level is low (<4 pmol\/L). Therefore, this is an exclusion criterion.\n\nBased on the patient's information, the patient is not eligible for the clinical trial because of the low AMH level. Therefore, the answer is B: excluded.","PROBA":0.9651971185},{"ID":"23538_33-2022_NCT03562039","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have moderate to advanced chronic periodontitis?\n\nYes, the patient has chronic periodontitis.\n\n#2: Does the patient have pockets \u2265 5 mm 6-8 weeks after phase I (non-surgical) therapy?\n\nYes, the patient has pockets \u2265 5 mm.\n\n#3: Does the patient have vertical 2 or 3 walls Intra-bony defects \u2265 3mm?\n\nYes, the patient has Intra-bony defects \u2265 3mm.\n\n#4: Is the patient able to come for follow-up appointments?\n\nYes, the patient is cooperative and able to come for follow-up appointments.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9366565821},{"ID":"33487_71-2021_NCT00938535","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being an African-American female aged 25-44 with a BMI of 25-34.9 kg\/m2.\n\n#2: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria of being currently pregnant or having given birth within the past 12 months.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9205920558},{"ID":"35338_75-2021_NCT00433654","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have, or is at risk of having, a heart beat that is too slow?\n\nYes, the patient has been diagnosed with Parkinson's disease, which can cause bradykinesia (slowness of movement) and tremors. This meets the inclusion criterion of having, or being at risk of having, a heart beat that is too slow.\n\n#2: Is the patient available for follow-up at the study center for the length of the study?\n\nYes, the patient is cooperative and available for follow-up.\n\n#3: Is the patient able and willing to undergo elective MRI scanning without sedation?\n\nNo, the patient is not able to undergo MRI scanning without sedation, as they are not able to lie still for the length of the scan. This meets the exclusion criterion of not being able to undergo MRI scanning without sedation.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9294410947},{"ID":"17086_36-2021_NCT01981590","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age requirement?\n\nYes, the patient is over 18 years old.\n\n#2: Is the patient undergoing a cardiac catheterization involving right heart catheterization and\/or EP procedures and\/or device implant?\n\nYes, the patient is undergoing a cardiac catheterization.\n\n#3: Is the patient willing and able to give informed consent?\n\nYes, the patient is willing and able to give informed consent.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9196945566},{"ID":"35550_75-2021_NCT02476240","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease by a Neurologist.\n\n#2: Is the patient able to stand unassisted for 2 minutes?\nYes, the patient is able to stand unassisted for 2 minutes.\n\n#3: Is the patient able to walk 10 meters unassisted?\nYes, the patient is able to walk 10 meters unassisted.\n\n#4: Does the patient understand English instructions?\nYes, the patient understands English instructions.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9293440573},{"ID":"5293_12-2021_NCT01302756","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Tricare Insurance Beneficiary (military insurance)?\nNo, the patient does not have Tricare Insurance Beneficiary (military insurance). Therefore, this patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.8723607857},{"ID":"27599_40-2022_NCT01190150","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a history of at least one year of cyclic heavy menstrual bleeding?\n\nYes, the patient has heavy menstrual cycles each month, indicating a history of at least one year of cyclic heavy menstrual bleeding, making her eligible for the clinical trial.\n\n#2: Does the patient report regularly occurring menstrual periods \u226410 days in duration, with 21-45 days from the start of one period to the start of the next menstrual period?\n\nYes, the patient's menstrual periods are regularly occurring and last \u226410 days, with a duration of 21-45 days between periods, which meets the inclusion criteria.\n\n#3: Does the patient have a diagnosis of heavy menstrual bleeding based on the medical judgment of the Principal Investigator?\n\nYes, the patient's heavy menstrual bleeding is confirmed by the medical judgment of the Principal Investigator, which is a requirement for inclusion in the clinical trial.\n\n#4: Is the patient either sexually inactive (abstinent) or using one of the following acceptable birth control methods and agree to continue its use throughout the study?\n\nYes, the patient is sexually inactive (abstinent), which meets the requirement for inclusion in the clinical trial.\n\n#5: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria, such as breast-feeding, known bleeding or coagulation disorders, or a history of abortion in the last 6 months.\n\nTherefore, based on the provided information and the inclusion and exclusion criteria for the clinical trial, the patient would likely be considered eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9275538848},{"ID":"27628_40-2022_NCT01391052","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have heavy periods?\nYes, the patient does have heavy periods.\n\n#2: Is the patient between 18-45 years old?\nYes, the patient is between 18-45 years old.\n\n#3: Does the patient have any of the exclusion criteria?\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9227470979},{"ID":"5322_12-2021_NCT01740583","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a structurally normal mitral valve?\n\nNo, the patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which means the mitral valve is not structurally normal. Therefore, the patient does not meet the inclusion criterion #1.\n\n#2: Does the patient have at least Grade 2 mitral regurgitation?\n\nYes, the patient has severe mitral regurgitation. Therefore, the patient meets the inclusion criterion #2.\n\n#3: What is the patient's left ventricular ejection fraction?\n\nThe patient's left ventricular ejection fraction is not less than 20% and not greater than 45%. Therefore, the patient meets the inclusion criterion #3.\n\n#4: What is the patient's left ventricular end diastolic diameter?\n\nThe patient's left ventricular end diastolic diameter is not less than 5.0 cm and not greater than 7.5 cm. Therefore, the patient meets the inclusion criterion #4.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the inclusion criterion #1 (structurally normal mitral valve).","PROBA":0.9503806976},{"ID":"27738_40-2022_NCT02304510","TOPIC_YEAR":2022,"RESPONSE":"The patient is a female aged between 18 and 50 years old (inclusive), which meets the inclusion criterion.\n\nThe patient has had prolonged oral bleeding immediately after a tooth extraction, which may be related to her heavy menstrual cycles. However, this is not explicitly mentioned in the exclusion criteria. Therefore, the patient's medical history of prolonged oral bleeding is not a reason for exclusion.\n\nThe patient takes no medications, which meets the exclusion criterion of not currently taking hormone therapy to induce menstruation.\n\nThe patient has a family history of excessive bleeding during menstrual periods, which may be relevant to the study's objective of assessing the prevalence of heavy menstrual bleeding. However, this is not explicitly mentioned in the exclusion criteria. Therefore, the patient's family history is not a reason for exclusion.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9145085518},{"ID":"27672_40-2022_NCT01769820","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a complaint of HMB?\nYes, the patient has prolonged oral bleeding immediately after a tooth extraction, which is a complaint of HMB.\n\n#2: Is the patient pre-menopausal?\nYes, the patient is 23 years old, which is pre-menopausal.\n\n#3: Does the patient describe menstrual cycles every 21-42 days?\nYes, the patient has heavy menstrual cycles each month.\n\n#4: Has the patient provided written informed consent prior to any study-related procedures?\nNot specified in the patient note, but it is assumed that the patient has provided informed consent since they are undergoing the clinical trial.\n\n#5: If of childbearing potential, does the patient agree to practice a non-hormonal method of contraception for the duration of the study or have a partner with a vasectomy?\nNot specified in the patient note.\n\nBased on the criteria listed in the clinical trial, the patient is eligible for the study. Therefore, the answer is:\n\nA: eligible","PROBA":0.9230401657},{"ID":"17312_36-2021_NCT03720392","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the age range of 18-80 years old specified in the inclusion criteria. Therefore, the patient meets the age criterion.\n\n#2: Gender\nThe patient is a woman, which is within the gender criteria of \"Men or women\" specified in the inclusion criteria. Therefore, the patient meets the gender criterion.\n\n#3: Medical condition\nThe patient has obesity, sleep apnea, PCO, and dissatisfaction with her body shape, which are all within the scope of the clinical trial. The patient does not have any of the exclusion criteria specified in the clinical trial, such as prior allogeneic hematopoietic stem cell transplantation or uncontrolled intercurrent illness. Therefore, the patient meets the medical condition criterion.\n\n#4: Physical function\nThe patient has adequate physical function, as measured by her cardiac, hepatic, renal, and pulmonary functions, which are all within normal limits. Therefore, the patient meets the physical function criterion.\n\n#5: Contraception\nThe patient is not pregnant or breastfeeding, and she is willing to use adequate contraception prior to study entry and for the duration of study participation. Therefore, the patient meets the contraception criterion.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9159274076},{"ID":"6752_15-2021_NCT01774162","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a detectable lesion?\n\nYes, the patient has a detectable lesion (pancreatic adenocarcinoma at the head of pancreas).\n\n#2: Is the lesion inaccessible to EUS-guided biopsy?\n\nNo, the lesion is accessible to EUS-guided biopsy.\n\n#3: Does the patient require tissue sampling?\n\nYes, the patient requires tissue sampling for diagnosis and staging of pancreatic adenocarcinoma.\n\n#4: Is the patient's coagulopathy under control?\n\nNo, the patient has a coagulopathy with an INR of 1.5, which is above the exclusion criterion of 1.5.\n\nTherefore, the patient is not eligible for the clinical trial due to coagulopathy with an uncorrectable INR > 1.5.","PROBA":0.9099717499},{"ID":"27979_40-2022_NCT03844776","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the age criteria?\n\nYes, the patient is between 16 and 70 years old, so they meet the age criteria.\n\n#2: Does the patient need surgical teeth extraction?\n\nYes, the patient requires surgical teeth extraction, which meets the inclusion criterion.\n\n#3: Is the patient allergic to co-amoxiclav, amoxicillin, or metronidazole?\n\nNo, there is no mention of any allergies in the patient note.\n\n#4: Is the patient taking warfarin medication?\n\nNo, there is no mention of any medications in the patient note.\n\nBased on the patient note and the inclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.9310852949},{"ID":"27939_40-2022_NCT03585712","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have prolonged oral bleeding?\nYes, the patient has prolonged oral bleeding.\n\n#2: Does the patient have heavy menstrual cycles?\nYes, the patient has heavy menstrual cycles.\n\n#3: Does the patient have a family history of excessive bleeding during menstrual periods?\nYes, the patient's mother and grandmother have also had excessive bleeding during menstrual periods.\n\n#4: Does the patient meet the inclusion criteria for the clinical trial?\nYes, the patient meets the inclusion criteria for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9139200303},{"ID":"35732_75-2021_NCT04051125","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Is the patient over the age of 18?\n\nYes, the patient is over the age of 18.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.8934246141},{"ID":"6744_15-2021_NCT01710254","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have confirmed persistent or paroxysmal AF?\n\nYes, the patient has confirmed persistent AF.\n\n#2: Does the patient have suspected coronary artery disease?\n\nYes, the patient has suspected coronary artery disease based on the CT abdomen without contrast showing a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass, consistent with pancreatic adenocarcinoma at the head of pancreas.\n\n#3: Is the patient over 60 years old or have any suspicion of abnormal kidney function?\n\nYes, the patient is over 60 years old.\n\n#4: Does the patient have any contraindications to MRI (pacemaker, metal implants)?\n\nNo, the patient does not have any contraindications to MRI.\n\n#5: Is the patient willing to undergo catheterization X-ray angiography?\n\nYes, the patient has undergone catheterization X-ray angiography.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9423332178},{"ID":"14175_30-2021_NCT03372772","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have primary hypothyroidism?\nYes, the patient has primary hypothyroidism, so this criterion is met.\n\n#2: Is the patient experiencing fatigue symptoms?\nYes, the patient is experiencing fatigue symptoms, so this criterion is met.\n\n#3: Is the patient receiving Levothyroxine treatment for at least 6 months?\nYes, the patient has been receiving Levothyroxine treatment for at least 6 months, so this criterion is met.\n\n#4: What are the patient's serum free thyroxine and Thyroid-stimulating hormone levels?\nThe patient's serum free thyroxine level is 0.2 ng\/dl, which is below the normal range of 0.80-1.80 ng\/dl. The patient's serum Thyroid-stimulating hormone level is 2.35 \u00b5IU\/ml, which is within the normal range of 0.35-5.50 \u00b5IU\/ml.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nTherefore, the answer is:\n\nA: eligible","PROBA":0.9377760163},{"ID":"27533_40-2022_NCT00663481","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the age criteria?\n\nYes, the patient is 23 years old, which is within the age range of 18-65 inclusive. Therefore, the patient meets the age criteria.\n\n#2: Does the patient meet the gender criteria?\n\nThe clinical trial is open to both males and females. The patient is a female, so she meets the gender criteria.\n\n#3: Does the patient meet the body mass index (BMI) criteria?\n\nThe patient's BMI is not specified in the patient note. However, based on the BMI range of 18 to 30 kg\/m2 and body weight of 45 to 95 kg, it is likely that the patient meets the BMI criteria.\n\n#4: Does the patient meet the smoking criteria?\n\nThe patient is not a smoker, so she meets the smoking criteria.\n\n#5: Does the patient have any clinically significant illness or laboratory abnormalities?\n\nThe patient has prolonged oral bleeding after a tooth extraction, which may be considered a clinically significant illness. However, the clinical trial exclusion criteria state that subjects with clinically significant illness within 21 days prior to dosing are excluded. Therefore, the patient does not meet the exclusion criteria.\n\n#6: Does the patient have any history of drug allergies or predisposing disorders?\n\nThere is no information in the patient note regarding drug allergies or predisposing disorders. Therefore, the patient does not meet the exclusion criteria.\n\n#7: Is the patient pregnant or lactating?\n\nThe patient is not pregnant or lactating, so she meets the exclusion criteria.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9381744895},{"ID":"30799_65-2021_NCT02770443","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dilated cardiomyopathy (DCM)?\nNo, the patient does not have DCM.\n\n#2: Does the patient have recovered LV function to > or = to 50% documented on 2 ECHO examinations?\nNo, the patient does not have recovered LV function.\n\n#3: Is the time from initial diagnosis of DCM more or equal to 24 month?\nNo, the patient does not meet this criterion.\n\n#4: Has the patient had a last hospitalization for decompensated HF > 1year ago?\nNo, the patient does not meet this criterion.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9359291257},{"ID":"17418_36-2021_NCT04599803","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the age range of 18-65 years for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Legal United States Resident\nThe patient is a high-school teacher married for 5 years, and it is likely that she is a legal resident of the United States. Therefore, she meets this criterion.\n\n#3: Able to speak and read English\nThe patient is able to speak and read English, as she is a high-school teacher. Therefore, she meets this criterion.\n\n#4: Own a smartphone with a data plan\nThe patient owns a smartphone and has a data plan, as she uses it to communicate with her students and colleagues. Therefore, she meets this criterion.\n\n#5: Consistent access to electricity and wifi for the duration of the study\nThe patient has consistent access to electricity and wifi, as she is a high-school teacher and has access to these resources at her school. Therefore, she meets this criterion.\n\n#6: Good candidate for PAP therapy, in the opinion of the managing clinician\nThe patient has been diagnosed with sleep apnea and is a good candidate for PAP therapy, as determined by the managing clinician. Therefore, she meets this criterion.\n\n#7: Without significant limitation in ability to participate in the study, in the opinion of the investigator\nThe patient does not have any significant limitations that would prevent her from participating in the study, as determined by the investigator. Therefore, she meets this criterion.\n\nBased on the above, the patient meets all the inclusion criteria for the clinical trial. Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.930431139},{"ID":"7089_15-2021_NCT04704466","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have cancer of the upper aero-digestive tract?\n\nNo, the patient has pancreatic adenocarcinoma, which is not a cancer of the upper aero-digestive tract. Therefore, the patient does not meet the inclusion criteria and is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.8882106826},{"ID":"14148_30-2021_NCT03096613","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have subclinical hypothyroidism?\n\nYes, the patient has subclinical hypothyroidism, as evidenced by her high TSH level (13 mU\/L) and low free T4 level (0.2 ng\/dl).\n\n#2: Does the patient have chronic heart failure (CHF)?\n\nYes, the patient has CHF, as evidenced by her symptoms of fatigue, weight gain, and abnormal spotting between menses, and her diagnosis of Hashimoto's thyroiditis.\n\n#3: Is the patient aged 18 years or older?\n\nYes, the patient is aged 33 years old, which meets the inclusion criterion.\n\n#4: Has the patient received standard HF therapy for at least 2 weeks?\n\nYes, the patient has received standard HF therapy for at least 2 weeks, as evidenced by her treatment with Levothyroxine.\n\n#5: Is the patient willing to provide informed consent?\n\nYes, the patient is willing to provide informed consent, as evidenced by her participation in the clinical trial.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9362351386},{"ID":"5533_12-2021_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient > 18 years old?\nYes, the patient is 34 years old, which is greater than 18 years old.\n\n#2: Does the patient have severe MR as read on a transthoracic echocardiographic study?\nYes, the patient has severe MR as read on a transthoracic echocardiographic study.\n\n#3: Is the mitral leaflet coaptation surface sufficient to reduce mitral regurgitation without undue leaflet tension?\nYes, the mitral leaflet coaptation surface is sufficient to reduce mitral regurgitation without undue leaflet tension.\n\n#4: Does the patient have degenerative mitral valve disease with mid-segment P2 prolapse?\nYes, the patient has degenerative mitral valve disease with mid-segment P2 prolapse.\n\n#5: Is the patient able to sign informed consent and able to return for follow-up?\nYes, the patient is able to sign informed consent and able to return for follow-up.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9558306747},{"ID":"35817_75-2021_NCT04750226","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient considered an adult?\nYes, the patient is an adult.\n\n#3: Has the patient completed the parent study (M15-736)?\nYes, the patient has completed the parent study.\n\n#4: Is the patient considered an unsuitable candidate to receive ABBV-951 for any reason?\nNo, the patient is not considered an unsuitable candidate.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.9241210218},{"ID":"35318_75-2021_NCT00220272","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient male or female?\nThe patient is male.\n\n#3: Is the patient over the age of 35?\nYes, the patient is over the age of 35.\n\n#4: Does the patient have a duration of the disease of less than 3 years since diagnosis?\nYes, the patient has a duration of the disease of less than 3 years since diagnosis.\n\n#5: Is the patient optimized on monotherapy by levodopa or a dopamine agonist?\nYes, the patient is optimized on monotherapy by levodopa or a dopamine agonist.\n\n#6: Does the patient have any indication of forms of parkinsonism other than PD?\nNo, there is no indication of forms of parkinsonism other than PD.\n\n#7: Does the patient have severe resting tremor?\nNo, the patient does not have severe resting tremor.\n\n#8: Does the patient have dyskinesia, fluctuations, or loss of postural reflexes?\nNo, the patient does not have dyskinesia, fluctuations, or loss of postural reflexes.\n\n#9: Is the patient taking any medications that are exclusion criteria?\nNo, the patient is not taking any medications that are exclusion criteria.\n\n#10: Does the patient have any other clinically significant or unstable medical disorder?\nNo, there is no evidence of any other clinically significant or unstable medical disorder.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9644463848},{"ID":"17337_36-2021_NCT03958487","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a chronic DCA (more than 3 months)?\n\nNo, the patient does not have a chronic DCA (more than 3 months).\n\n#2: Does the patient have cognitive deficits relative to executive\/monitoring functions and\/or memory?\n\nYes, the patient has cognitive deficits relative to executive\/monitoring functions and\/or memory.\n\n#3: Is the patient at least 18 years old?\n\nYes, the patient is at least 18 years old.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.944794877},{"ID":"7000_15-2021_NCT03955081","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have small bowel disease indicated for deep enteroscopy?\n\nYes, the patient has a history of pancreatic adenocarcinoma at the head of pancreas, which is a type of small bowel disease.\n\n#2: Is the patient at least 18 years old?\n\nYes, the patient is 70 years old, which is above the age of 18.\n\n#3: Is the patient not of child-bearing age and not currently pregnant or planning to become pregnant within the study period?\n\nYes, the patient is a 70-year-old woman, so she is not of child-bearing age.\n\n#4: Does the patient not have any contraindication to standard enteroscopy?\n\nThe patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, and hypothyroidism, but these conditions do not appear to be contraindications to standard enteroscopy.\n\nTherefore, based on the inclusion and exclusion criteria, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9490591741},{"ID":"35694_75-2021_NCT03793491","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient have motor fluctuations and\/or disabling dyskinesia?\n\nYes, the patient presents with motor fluctuations and disabling dyskinesia.\n\n#3: Is the patient in need of a second-line treatment?\n\nYes, the patient is in need of a second-line treatment.\n\n#4: Is the patient able to give informed consent?\n\nYes, the patient is able to give informed consent.\n\n#5: Does the patient have a social security number?\n\nYes, the patient has a social security number.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9464668293},{"ID":"30459_65-2021_NCT00466713","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have nonischemic dilated cardiomyopathy?\n\nYes, the patient has nonischemic dilated cardiomyopathy, as confirmed by molecular analysis 7 years ago.\n\n#2: Is the patient currently experiencing NYHA class I-II congestive heart failure?\n\nYes, the patient is currently experiencing NYHA class I-II congestive heart failure.\n\n#3: Has the patient been treated with a stable comprehensive heart failure regimen for at least 3 months?\n\nYes, the patient has been treated with a stable comprehensive heart failure regimen for at least 3 months, including beta-blockers and ACE-inhibitors or angiotensin receptor blockers unless intolerant.\n\n#4: Is the patient's age greater than 18 years?\n\nYes, the patient's age is greater than 18 years.\n\nBased on the answers to these questions, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9344415654},{"ID":"30469_65-2021_NCT00539448","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, as confirmed by molecular analysis 7 years ago.\n\n#2: Is the patient newly diagnosed with type 1 diabetes?\n\nNo, the patient has had type 1 diabetes for 7 years. Therefore, they do not meet the inclusion criterion of being newly diagnosed.\n\n#3: Is the patient treated with basal-bolus regimen including 3 or more injections of Regular Human Insulin per day?\n\nYes, the patient is treated with basal-bolus regimen including 3 or more injections of Regular Human Insulin per day.\n\n#4: Is the patient's BMI between 26-40 kg\/m2?\n\nYes, the patient's BMI is between 26-40 kg\/m2.\n\n#5: What is the patient's HbA1c level?\n\nThe patient's HbA1c level is 6.5%, which is within the inclusion criterion of 7.5%-10%.\n\n#6: What is the patient's median 2-hour post-prandial glucose level?\n\nThe patient's median 2-hour post-prandial glucose level is more than or equal to 140 mg\/dl (more than or equal to 7.8 mmol\/L), which meets the inclusion criterion.\n\n#7: What is the patient's FPG level?\n\nThe patient's FPG level is more than or equal to 120 mg\/dl (more than or equal to 6.7 mmol\/L), which meets the inclusion criterion.\n\n#8: Is the patient willing and able to inject insulin Glargine therapy?\n\nYes, the patient is willing and able to inject insulin Glargine therapy.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9674042822},{"ID":"6689_15-2021_NCT01250574","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a suspected infection in the GI tract or after abdominal surgery?\n\nYes, the patient has a suspected infection in the GI tract (abdominal mass with fevers\/rigors and bandemia) after abdominal surgery (recently underwent EUS with biopsy).\n\n#2: Is the patient at least 18 years old?\n\nNo, the patient is 70 years old, which is less than 18 years old.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9259466993},{"ID":"13995_30-2021_NCT01054443","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have immune thrombocytopenia (ITP)?\n\nYes, the patient has ITP, so we can check the next criterion.\n\n#2: Is the patient's platelet count < 30,000\/\u03bcL if not taking medications or < 50,000\/\u03bcL despite concomitant steroids or other ITP therapies?\n\nYes, the patient's platelet count is < 30,000\/\u03bcL, so we can check the next criterion.\n\n#3: Is the patient receiving stable dosages of cyclosporine A, mycophenolate mofetil, azathioprine, or danazol?\n\nNo, the patient is not receiving these medications, so we can check the next criterion.\n\n#4: Has the patient had a diagnostic bone marrow aspiration?\n\nYes, the patient has had a diagnostic bone marrow aspiration, so we can check the next criterion.\n\n#5: Is the patient > 60 years old?\n\nNo, the patient is not > 60 years old, so we can check the final criterion.\n\n#6: Is the patient eligible for the clinical trial?\n\nYes, the patient meets all the inclusion criteria and none of the exclusion criteria, so the patient is eligible for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9592600648},{"ID":"13964_30-2021_NCT00531713","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypothyroidism?\nYes, the patient has been diagnosed with hypothyroidism.\n\n#2: Does the patient have S-TSH > 20 at diagnosis?\nYes, the patient's S-TSH level was 13 mU\/L, which is above the inclusion criterion of > 20.\n\n#3: Does the patient have Anti-TPO > 300?\nYes, the patient's Anti-TPO level was 120 IU\/ml, which is above the inclusion criterion of > 300.\n\n#4: Is the patient on stable T4-substitution therapy?\nYes, the patient is currently taking Levothyroxine (T4) and has been on stable therapy.\n\n#5: Is the patient within the age range of 18-75 years?\nYes, the patient is within the age range of 18-75 years.\n\n#6: Does the patient have any exclusion criteria?\nNo, the patient does not have any of the exclusion criteria (pregnant women, thyroid cancer, T3 treatment, or post-partum thyroiditis).\n\nTherefore, based on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9368864373},{"ID":"17141_36-2021_NCT02450097","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is greater than the minimum age requirement of 18 years old. Therefore, the patient meets the age inclusion criterion.\n\n#2: BMI\nThe patient has a BMI of 41.54, which is greater than the minimum BMI requirement of 23-37. Therefore, the patient meets the BMI inclusion criterion.\n\n#3: Waist Circumference\nThe patient's waist circumference is not provided. However, based on the exclusion criteria, the patient would not meet the waist circumference requirement if it were less than 80 cm or less for women and 94 cm or less for men. Therefore, the patient does not meet the waist circumference inclusion criterion.\n\n#4: Total Fat Percentage\nThe patient's total fat percentage is not provided. However, based on the exclusion criteria, the patient would not meet the total fat percentage requirement if it were less than 23%. Therefore, the patient does not meet the total fat percentage inclusion criterion.\n\n#5: Treatment with Insulin and Sulfonylurea Drugs\nThe patient is not being treated with insulin and sulfonylurea drugs, which is an exclusion criterion. Therefore, the patient meets the exclusion criterion.\n\n#6: Chronic Kidney Disease (CKD) Stage 4 and 5\nThe patient does not have a history of CKD stage 4 and 5, which is an exclusion criterion. Therefore, the patient meets the exclusion criterion.\n\n#7: Pregnancy and Breast-feed\nThe patient is not pregnant or breast-feeding, which is an exclusion criterion. Therefore, the patient meets the exclusion criterion.\n\n#8: Active Athletes\nThe patient is not an active athlete, which is an exclusion criterion. Therefore, the patient meets the exclusion criterion.\n\n#9: History of Eating Disorder\nThe patient does not have a history of eating disorder, which is an exclusion criterion. Therefore, the patient meets the exclusion criterion.\n\n#10: Participation in Another Ongoing Study\nThe patient is not participating in another ongoing study, which is an exclusion criterion. Therefore, the patient meets the exclusion criterion.\n\nBased on the above criteria, the patient does not meet the inclusion criteria for the clinical trial. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9521814251},{"ID":"27610_40-2022_NCT01261936","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a diagnosed bleeding disorder?\nNo, the patient does not have a diagnosed bleeding disorder.\n\n#2: Is the patient experiencing excessive menstrual bleeding?\nYes, the patient is experiencing excessive menstrual bleeding.\n\n#3: Does the patient meet the age criteria (18-45 years old)?\nYes, the patient is within the age range of 18-45 years old.\n\n#4: Is the patient willing to sign a consent form?\nYes, the patient is willing to sign a consent form.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9185094119},{"ID":"16975_36-2021_NCT01013207","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because she is not using a ResMed mask system.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not meet the exclusion criteria because she is not pregnant and she is able to comprehend English and provide written informed consent.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9002876915},{"ID":"5548_12-2021_NCT04571372","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of age \u2265 19 yrs and severe aortic stenosis or severe aortic regurgitation.\n\n#2: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria of pre-existing acute kidney injury, pre-existing end stage kidney disease, or life expectancy < 12 months.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.931376028},{"ID":"6716_15-2021_NCT01476995","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a qualifying medical diagnosis?\n\nNo, the patient does not have a qualifying medical diagnosis. The patient has a history of CAD and recent abdominal mass with fevers\/rigors and bandemia, but these do not match any of the qualifying diagnoses listed in the clinical trial.\n\n#2: Is the patient at least 18 years old and less than 85 years old?\n\nYes, the patient is at least 18 years old and less than 85 years old.\n\n#3: Is the patient willing and able to provide informed consent?\n\nNo, the patient is not willing and able to provide informed consent because they are currently being treated with IV antibiotics and will continue to be treated until seen by ID as an outpatient.\n\nTherefore, based on the criteria listed in the clinical trial, the patient is not eligible for the study.","PROBA":0.9053843547},{"ID":"35649_75-2021_NCT03416452","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient at least 18 years old?\n\nYes, the patient is 55 years old, which is above the age of 18.\n\n#2: Can the patient provide informed consent?\n\nYes, the patient is alert and cooperative, and does not have any signs of dementia.\n\n#3: Does the patient have a clinical diagnosis of Parkinson disease by U.K. Parkinson Society Brain Bank Criteria?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#4: Is the patient stage II - III on the Hoehn and Yahr scale?\n\nYes, the patient is stage II - III on the Hoehn and Yahr scale.\n\n#5: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient is eligible to participate.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9273081124},{"ID":"33917_71-2021_NCT04299100","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have chronic non-cancer pain for > 3 months?\n\nYes, the patient has chronic non-cancer pain for > 3 months, so this criterion is met.\n\n#2: Does the patient report sleep disturbances?\n\nYes, the patient reports sleep disturbances, such as difficulty falling asleep, staying asleep, or problems waking up too early.\n\n#3: Is the patient an adult (\u226518 years old)?\n\nYes, the patient is an adult.\n\n#4: Does the patient have cognitive capability?\n\nYes, the patient has cognitive capability.\n\nTherefore, based on the inclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.9183781286},{"ID":"5410_12-2021_NCT02771275","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have severe mitral regurgitation?\n\nYes, the patient has severe mitral regurgitation, which meets the inclusion criterion.\n\n#2: Is the patient over 18 years old?\n\nYes, the patient is over 18 years old, which meets the inclusion criterion.\n\n#3: Does the patient have degenerative mitral valve disease?\n\nYes, the patient has degenerative mitral valve disease, which meets the inclusion criterion.\n\n#4: Is the patient able to sign informed consent and return for follow-up?\n\nYes, the patient is able to sign informed consent and return for follow-up, which meets the inclusion criterion.\n\n#5: Does the patient have any exclusion criteria?\n\nThe patient has Marfan's syndrome, which is an exclusion criterion. However, the patient is willing to participate in the study and has been deemed eligible by the investigator.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9348134205},{"ID":"14092_30-2021_NCT02393183","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mild TED of less than 18 months duration?\n\nYes, the patient has mild TED of less than 18 months duration.\n\n#2: Is the patient euthyroid?\n\nYes, the patient is euthyroid.\n\n#3: Is the patient between 18-70 years old?\n\nYes, the patient is between 18-70 years old.\n\n#4: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9321111672},{"ID":"5435_12-2021_NCT03154034","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have symptomatic severe mitral regurgitation?\n\nYes, the patient has symptomatic severe mitral regurgitation.\n\n#2: Is the patient referred for diagnostic work-up and heart team discussion?\n\nYes, the patient is referred for diagnostic work-up and heart team discussion.\n\n#3: Has the patient declared informed consent?\n\nNo, the patient has not declared informed consent.\n\nBased on the criteria, the patient is not eligible for the clinical trial. The patient does not meet the informed consent requirement.","PROBA":0.9047332303},{"ID":"17184_36-2021_NCT02723617","TOPIC_YEAR":2021,"RESPONSE":"#1: Check if the patient's BMI is within the inclusion criteria range of 20-40 kg\/m2.\n\nYes, the patient's BMI is 32, which is within the inclusion criteria range.\n\n#2: Check if the patient is a non-smoker.\n\nYes, the patient is a non-smoker.\n\n#3: Check if the patient's fasting glucose is \u2264 126 mg\/dl.\n\nNo, the patient's fasting glucose is 98 mg\/dl, which is above the inclusion criteria of \u2264 126 mg\/dl.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9180886258},{"ID":"6963_15-2021_NCT03559348","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have cyto-\/histologically confirmed, recurrent or metastatic adenocarcinoma of the pancreas?\n\nYes, the patient has cyto-\/histologically confirmed, recurrent or metastatic adenocarcinoma of the pancreas.\n\n#2: Does the patient have disease measurable or evaluable on x-ray, computed tomography scan, or physical examination?\n\nYes, the patient has disease measurable or evaluable on x-ray, computed tomography scan, or physical examination.\n\n#3: Has the patient had prior chemotherapy for metastatic pancreatic cancer?\n\nNo, the patient has not had prior chemotherapy for metastatic pancreatic cancer.\n\n#4: Has the patient had prior radiotherapy?\n\nYes, the patient has had prior radiotherapy.\n\n#5: Is the patient willing to have an indwelling venous catheter implanted?\n\nYes, the patient is willing to have an indwelling venous catheter implanted.\n\n#6: Is the patient of reproductive potential and willing to use an effective contraceptive method?\n\nNo, the patient is not of reproductive potential.\n\n#7: Has the patient signed written informed consent?\n\nYes, the patient has signed written informed consent.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9636111717},{"ID":"17047_36-2021_NCT01624155","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age criteria?\n\nNo, the patient is 32 years old, which is outside the age range of 18-45 years old. Therefore, the patient does not meet the age criteria and is not eligible for the clinical trial.","PROBA":0.837124134},{"ID":"35581_75-2021_NCT02768896","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient ambulatory?\nYes, the patient is ambulatory.\n\n#3: Can the patient sign a written informed consent?\nYes, the patient is alert and cooperative, and can sign a written informed consent.\n\nBased on the criteria for the clinical trial, the patient would be considered eligible for the trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.8993841777},{"ID":"35822_75-2021_NCT04784585","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 55 years old, which is within the inclusion criteria of 18-70 years old. Therefore, the patient meets the age requirement.\n\n#2: BMI\nThe patient has a BMI of 30, which is within the inclusion criteria of 25-50 kg\/m-squared. Therefore, the patient meets the BMI requirement.\n\n#3: Cardiovascular disease risk factors\nThe patient has hypertension and hypercholesterolemia, which are both cardiovascular disease risk factors. Therefore, the patient meets the requirement for having one or more cardiovascular disease risk factors.\n\n#4: Able to walk 2 city blocks without stopping\nThe patient is able to walk 2 city blocks without stopping, which meets the requirement of being able to walk 2 city blocks without stopping.\n\nSince the patient meets all the inclusion criteria and does not have any of the exclusion criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9248536898},{"ID":"33481_71-2021_NCT00909766","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI of 30 to 40 kg\/m\u00b2, inclusive?\n\nYes, the patient has a BMI of 41.54, which is well within the inclusive range of 30 to 40 kg\/m\u00b2.\n\n#2: Is the patient obese as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations?\n\nYes, the patient is obese based on her medical history, physical examination, and laboratory results.\n\n#3: Is the patient not of childbearing potential (ie, postmenopausal or surgically sterile)?\n\nNo, the patient is not postmenopausal or surgically sterile, so she is not excluded based on this criterion.\n\n#4: Does the patient have any clinically significant history or presence of any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the criteria provided, the patient would be eligible for the clinical trial.","PROBA":0.9341708817},{"ID":"30522_65-2021_NCT01005303","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have New York Heart Association Class II or III heart failure?\n\nYes, the patient has New York Heart Association Class II heart failure (mild dyspnea during activities).\n\n#2: Is the patient already on or tried on best known medical treatment (ACE inhibitor and beta-blocker)?\n\nYes, the patient is currently taking ACE inhibitors and beta-blockers.\n\n#3: Is the patient stable for a period of at least 6 weeks?\n\nYes, the patient is stable for at least 6 weeks.\n\n#4: Does the patient have a left ventricular ejection fraction of less than or equal to 45%?\n\nYes, the patient has a left ventricular ejection fraction of less than or equal to 45%.\n\nBased on the answers to these questions, the patient is eligible for the clinical trial.","PROBA":0.9362820581},{"ID":"35656_75-2021_NCT03491111","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of stroke?\n\nYes, the patient has a diagnosis of stroke.\n\n#2: Is the patient capable of performing voluntary respiratory maneuvers?\n\nYes, the patient is capable of performing voluntary respiratory maneuvers.\n\nBased on the criteria for the clinical trial, the patient would be considered eligible for the study. Therefore, the answer is:\n\nA: eligible","PROBA":0.8883284536},{"ID":"33744_71-2021_NCT02910869","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because they did not complete the MOVE! or TeleMOVE! programs between 2006-2015, and they did not attend at least 75% of classes for group A cohort or participate in >75% of activities for group B cohort. Therefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.903432241},{"ID":"35748_75-2021_NCT04174729","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nNo, the patient does not have Parkinson's disease.\n\n#2: Is the patient right-handed?\nYes, the patient is right-handed.\n\n#3: Does the patient have preserved cognitive functions?\nYes, the patient has preserved cognitive functions.\n\n#4: Does the patient have any neurological disorders?\nNo, the patient does not have any neurological disorders.\n\n#5: Does the patient meet the age requirements?\nYes, the patient is within the age range of 20-39 years old.\n\n#6: Does the patient meet the grip strength requirements?\nNo, the patient does not meet the grip strength requirements. The patient has a grip strength of 45.08 \u00b1 0.67 kg, which is below the minimum requirement of 46.05 \u00b1 0.47 kg for men aged 30-39 years old.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9393645502},{"ID":"35491_75-2021_NCT01952678","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease or Essential Tremor?\n\nYes, the patient has Parkinson's disease (PD).\n\n#2: Is the patient non-Caucasian?\n\nNo, the patient is Caucasian.\n\n#3: Does the patient have existing diagnostic-quality and interpretable DaTscan SPECT images of the brain?\n\nYes, the patient has existing diagnostic-quality and interpretable DaTscan SPECT images of the brain.\n\n#4: Is the patient matched by final clinical diagnosis, sex, and age (\u00b15 years) with a non-Caucasian participant?\n\nNo, the patient is not matched with a non-Caucasian participant.\n\nBased on the criteria, the patient is not eligible for the clinical trial because they are Caucasian and not matched with a non-Caucasian participant.\n\nTherefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9438086564},{"ID":"35422_75-2021_NCT01246336","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient have severe dementia?\n\nNo, the patient does not have severe dementia.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9025002359},{"ID":"7018_15-2021_NCT04113499","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient 18 years or older?\n\nYes, the patient is 70 years old, which is above the age of 18, so this criterion is met.\n\n#2: Does the patient have a history of acute pancreatitis?\n\nYes, the patient has a history of acute pancreatitis, as confirmed by the presence of abdominal pain characteristic of acute pancreatitis, and serum lipase\/amylase levels that are elevated above the upper limit of normal.\n\n#3: Does the patient have a necrotic collection diagnosed on MRI or CT abdomen\/pelvis?\n\nYes, the patient has a necrotic collection diagnosed on CT abdomen\/pelvis, which meets this criterion.\n\n#4: Is the necrotic collection amenable to EUS-guided drainage?\n\nYes, the patient's necrotic collection is amenable to EUS-guided drainage, as it is visualized on EUS and can be drained using this procedure.\n\n#5: Does the patient have a suspected or confirmed infected necrotic collection?\n\nYes, the patient has a suspected\/confirmed infected necrotic collection, as there is evidence of gas in the necrotic collection on cross-sectional imaging and positive culture of necrotic tissue obtained preprocedure or at first intervention.\n\n#6: Is the patient able to undergo general anesthesia?\n\nYes, the patient is able to undergo general anesthesia, as there is no indication that they are unable to tolerate it.\n\nBased on the criteria listed, the patient is eligible for the clinical trial.","PROBA":0.9351201797},{"ID":"14186_30-2021_NCT03529630","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have inverted nipples?\nNo, the patient does not have inverted nipples.\n\n#2: Is the patient pregnant?\nNo, the patient is not pregnant.\n\n#3: Is the patient able to read and write?\nYes, the patient is able to read and write.\n\n#4: Does the patient have any medical conditions that could interfere with breastfeeding?\nNo, the patient does not have any medical conditions that could interfere with breastfeeding.\n\n#5: Is the patient willing to use the WHO syringe technique for management of inverted nipples?\nNo, the patient is not willing to use the WHO syringe technique.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9463389374},{"ID":"14252_30-2021_NCT04249271","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of infertility?\n\nYes, the patient has a history of infertility.\n\n#2: Does the patient have known thyroidal function (TSH, anti-TPO) test results?\n\nYes, the patient has known TSH and anti-TPO test results.\n\n#3: Does the patient have any other endocrine pathology or manifest thyroidal pathology?\n\nNo, the patient does not have any other endocrine pathology or manifest thyroidal pathology.\n\n#4: Is the patient contraindicated against pregnancy?\n\nNo, the patient is not contraindicated against pregnancy.\n\n#5: Does the patient have a history of repeated miscarriage (3 or more)?\n\nNo, the patient does not have a history of repeated miscarriage (3 or more).\n\n#6: Is the patient a heavy smoker (20 cig per day or more)?\n\nNo, the patient is not a heavy smoker (20 cig per day or more).\n\nBased on the answers to these questions, the patient is eligible for the clinical trial.","PROBA":0.951226357},{"ID":"35513_75-2021_NCT02086825","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have cirrhosis of the liver?\n\nYes, the patient has cirrhosis of the liver based on biopsy or clinical and radiographic criteria. Therefore, the patient meets the first inclusion criterion.\n\n#2: Does the patient have acute renal failure?\n\nYes, the patient has acute renal failure (increase in baseline creatinine of 0.5mg\/dL to a value of >2.0 mg\/dL within 3 days). Therefore, the patient meets the second inclusion criterion.\n\n#3: Is the patient able to provide informed consent?\n\nYes, the patient is able to provide informed consent (Grade 0 to 1 HE). Therefore, the patient meets the third inclusion criterion.\n\n#4: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria (previous history of sensitivity\/allergy to lactulose or rifaximin or rifampin, pregnancy, or inability to obtain informed consent). Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is eligible for the clinical trial.","PROBA":0.9542609698},{"ID":"17430_36-2021_NCT04646252","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of coronary artery disease?\nNo, the patient does not have a history of coronary artery disease. Therefore, this exclusion criterion does not apply.\n\n#2: Does the patient have a history of peripheral arterial disease?\nNo, the patient does not have a history of peripheral arterial disease. Therefore, this exclusion criterion does not apply.\n\n#3: Does the patient have a history of heart failure?\nNo, the patient does not have a history of heart failure. Therefore, this exclusion criterion does not apply.\n\n#4: Does the patient have a history of stroke?\nNo, the patient does not have a history of stroke. Therefore, this exclusion criterion does not apply.\n\n#5: Does the patient have hepatic failure?\nNo, the patient does not have hepatic failure. Therefore, this exclusion criterion does not apply.\n\n#6: Does the patient have renal failure?\nNo, the patient does not have renal failure. Therefore, this exclusion criterion does not apply.\n\n#7: Does the patient have active neoplasia?\nNo, the patient does not have active neoplasia. Therefore, this exclusion criterion does not apply.\n\n#8: Is the patient's diabetes mellitus poorly controlled?\nNo, the patient's diabetes mellitus is not poorly controlled (Hba1C<7%). Therefore, this exclusion criterion does not apply.\n\nBased on the provided information, the patient is eligible for the clinical trial.\n\nTherefore, the answer is: A: eligible.","PROBA":0.9612112802},{"ID":"25424_53-2021_NCT04490252","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of primary glomerulonephritis?\n\nYes, the patient has a history of primary glomerulonephritis, so this criterion is met.\n\n#2: Does the patient have an eGFR between 60 ml\/min and 30 ml\/min?\n\nNo, the patient's eGFR is not between 60 ml\/min and 30 ml\/min. This criterion is not met.\n\nSince the patient does not meet one of the inclusion criteria, they are not eligible for the clinical trial. Therefore, the answer is B: excluded.","PROBA":0.9247261145},{"ID":"28073_40-2022_NCT04526275","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have Fitzpatrick skin type 1-3?\nNo, the patient has dark skin (Fitzpatrick skin type 4-6). Therefore, the patient is not eligible based on the inclusion criteria.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.8177962351},{"ID":"11929_17-2022_NCT04110015","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a retinal, glaucoma, or neuro-ophthalmic disorder?\n\nNo, the patient does not have any of these disorders, so this criterion is not met.\n\n#2: Is the patient able to comprehend instructions and perform visual fields?\n\nYes, the patient is able to comprehend instructions and perform visual fields, so this criterion is met.\n\n#3: Does the patient have a complete clinical file and a specific diagnosis?\n\nYes, the patient has a complete clinical file and a specific diagnosis, so this criterion is met.\n\nBased on the criteria, the patient is not eligible for the clinical trial. Therefore, the answer is B: excluded.","PROBA":0.9067203678},{"ID":"14150_30-2021_NCT03103776","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being at least 18 years old and being referred to the ENT service of the CHU of Amiens for thyroidectomy in the context of a goitre, a Graves' disease, or a thyroiditis of Hashimoto.\n\n#2: Does the patient meet any exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria of being a minor or being under tutorship or curatorship.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9259802565},{"ID":"16918_36-2021_NCT00489333","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet any of the inclusion criteria?\n\nYes, the patient meets three of the inclusion criteria:\n\n* BMI \u226530 kg\/m2 (BMI = 41.54)\n* Fasting blood glucose >100 mg\/dl (FBS = 98 mg\/dl)\n* Blood pressure >130\/85 mm Hg (BP = 130\/80)\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.925766047},{"ID":"23201_33-2022_NCT01080534","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a male who is 20 years old, which meets the inclusion criterion of being a male subject in the range of age from 18 to 55 years.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not have any medical or surgical conditions that might significantly interfere with the functioning of gastrointestinal tract, blood-forming organs, etc. (exclusion criterion #2). He also does not have a history or presence of cardiovascular, renal, hepatic, ophthalmic, pulmonary, neurological, metabolic, haematological, gastrointestinal, endocrine, immunological or psychiatric diseases. (exclusion criteria #3-12). He is not currently taking any medication, which meets the exclusion criterion #6. He is not a smoker, which meets the exclusion criterion #8. He does not have any contraindication to blood sampling, which meets the exclusion criterion #7. He does not have a history or presence of malignancy or other serious diseases, which meets the exclusion criterion #5.\n\nTherefore, the patient meets all the inclusion criteria and none of the exclusion criteria, so he is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9128992393},{"ID":"27614_40-2022_NCT01307007","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria. She is a female with a history of heavy uterine bleeding within the past 6 months, and her screening visit central laboratory hemoglobin level is < 12 g\/dL, which meets the criterion of iron deficiency anemia.\n\n#2: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria. She does not have a known hypersensitivity reaction to any component of ferric carboxymaltose or iron dextran, and she does not have any history of primary hypophosphatemic disorder or hypophosphatemia < 2.6 mg\/dL. She is not currently being treated with intravenous iron, ESA, red blood cell transfusion, radiotherapy, or chemotherapy, and she does not have any non-viral infection or active hepatitis. She is not pregnant or sexually active, and she is willing to use an acceptable form of contraception. She does not have any other laboratory abnormality, medical condition, or psychiatric disorder that would put her disease management at risk or prevent her from complying with study requirements.\n\nTherefore, based on the information provided, the patient would be eligible for the clinical trial.","PROBA":0.9313018835},{"ID":"5319_12-2021_NCT01719211","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mitral valve prolapse?\nYes, the patient has mitral valve prolapse.\n\n#2: Is the patient willing to undergo mitral valve repair\/replacement surgery?\nYes, the patient is prepared to undergo surgery.\n\n#3: Does the patient have other mitral valve diseases?\nNo, the patient does not have other mitral valve diseases.\n\nBased on the criteria for the clinical trial, the patient is eligible for the study. Therefore, the answer is:\n\nA: eligible","PROBA":0.8979898086},{"ID":"6908_15-2021_NCT03116360","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 70 years old, which is within the inclusion criteria age range of 14 years and up. Therefore, the patient meets the age criterion.\n\n#2: Suspected acute stress fracture of the lower extremity\nThe patient presents with a history of abdominal mass, fevers, and bandemia, which suggests a possible diagnosis of acute stress fracture of the lower extremity. Therefore, the patient meets this criterion.\n\n#3: Symptoms < 4 weeks\nThe patient's symptoms have been present for less than 4 weeks, which meets this criterion.\n\n#4: X-ray ordered by clinician\nThe patient has already undergone an x-ray, which was ordered by a clinician, and meets this criterion.\n\n#5: No previous diagnosis of acute stress fracture in the location of interest\nThe patient does not have a previous diagnosis of acute stress fracture in the location of interest, which meets this criterion.\n\n#6: No previous XR or MRI obtained at an outside clinic\/facility prior to presentation\nThe patient has not had any previous imaging studies (x-ray or MRI) performed at an outside clinic\/facility prior to presentation, which meets this criterion.\n\n#7: No previously implanted hardware (ex. orthopedic screws or plates) at location of interest\nThe patient does not have any previously implanted hardware at the location of interest, which meets this criterion.\n\n#8: Symptoms > 8 weeks\nThe patient's symptoms have not been present for more than 8 weeks, which does not meet this criterion.\n\n#9: Depth from skin surface to bone surface that exceeds the capability of ultrasound for visualization\nThe patient's condition does not have a depth from skin surface to bone surface that exceeds the capability of ultrasound for visualization, which meets this criterion.\n\n#10: Pregnant (self-reported)\nThe patient is not pregnant, which meets this criterion.\n\nBased on the criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9606759172},{"ID":"5501_12-2021_NCT03982017","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have acute decompensated heart failure?\nYes, the patient has acute decompensated heart failure.\n\n#2: Does the patient have left ventricular systolic or diastolic heart failure?\nYes, the patient has left ventricular systolic heart failure.\n\n#3: Does the patient own a smartphone with a data plan?\nNo, the patient does not own a smartphone with a data plan.\n\n#4: Is the patient being discharged to home?\nYes, the patient is being discharged to home.\n\n#5: Is the patient unable to provide consent or comply with the intervention?\nNo, the patient is able to provide consent and comply with the intervention.\n\n#6: Is the patient currently enrolled in a remote monitoring\/telehealth program?\nNo, the patient is not currently enrolled in a remote monitoring\/telehealth program.\n\nBased on the criteria, the patient is not eligible for the clinical trial because they do not own a smartphone with a data plan, which is a requirement for participation. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9507012986},{"ID":"5247_12-2021_NCT00483236","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient fulfill the surgical criteria set by the 2006 ACC\/AHA guidelines for the management of patients with valvular heart disease?\n\nYes, the patient has severe mitral regurgitation with left ventricular dysfunction (LVEF < or = 40%) on maximal medical therapy, which fulfills the surgical criteria set by the 2006 ACC\/AHA guidelines.\n\n#2: Does the patient have symptomatic mitral regurgitation?\n\nYes, the patient is symptomatic with severe mitral regurgitation.\n\n#3: Is the patient on maximal medical therapy?\n\nYes, the patient is on maximal medical therapy.\n\nBased on the above, the patient fulfills all the inclusion criteria and none of the exclusion criteria, so the patient is eligible for the clinical trial.\n\nTherefore, the patient is \"eligible\" for the clinical trial.","PROBA":0.9319126153},{"ID":"17258_36-2021_NCT03279432","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI of 41.54, which is considered obese?\n\nYes, the patient has a BMI of 41.54, which is considered obese.\n\n#2: Does the patient have a history of prior pregnancies?\n\nNo, the patient does not have a history of prior pregnancies.\n\n#3: Is the patient a high-school teacher?\n\nYes, the patient is a high-school teacher.\n\n#4: Does the patient have sleep apnea?\n\nYes, the patient has sleep apnea.\n\n#5: Does the patient have PCO?\n\nYes, the patient has PCO.\n\n#6: Is the patient dissatisfied with her body shape?\n\nYes, the patient is dissatisfied with her body shape.\n\n#7: Does the patient have a history of using diets and exercise to lose weight?\n\nYes, the patient has a history of using diets and exercise to lose weight.\n\n#8: Does the patient have a normal cardiac assessment and joints and ROM within normal limits?\n\nYes, the patient has a normal cardiac assessment and joints and ROM within normal limits.\n\n#9: Is the patient willing to participate in the clinical trial?\n\nNot applicable, as the patient is not a participant in the clinical trial.\n\nBased on the criteria for the clinical trial, the patient is eligible for the study.","PROBA":0.9275703201},{"ID":"33531_71-2021_NCT01206413","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI of 41.5, which is greater than the inclusion criteria of 41.54?\n\nYes, the patient has a BMI of 41.5, which is greater than the inclusion criteria of 41.54. Therefore, the patient meets the inclusion criteria for the clinical trial.\n\n#2: Does the patient have any of the exclusion criteria, such as physician-diagnosed thyroid disease or diabetes, or who were menopausal or any other disease that could be influenced by intervention?\n\nNo, the patient does not have any of the exclusion criteria. Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is eligible for the clinical trial.","PROBA":0.9155320471},{"ID":"17378_36-2021_NCT04279600","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a Body Mass Index (BMI) of 30 to 40 kg\/m\u00b2?\n\nYes, the patient has a BMI of 41.54, which is well within the range of 30 to 40 kg\/m\u00b2.\n\n#2: Is the patient sedentary?\n\nNo, the patient is not sedentary. They are a high-school teacher and are physically active.\n\n#3: Does the patient have any associated co-morbidities?\n\nNo, the patient does not have any associated co-morbidities.\n\n#4: Is the patient a woman?\n\nYes, the patient is a woman.\n\n#5: Does the patient meet all of the inclusion criteria and none of the exclusion criteria?\n\nYes, the patient meets all of the inclusion criteria and none of the exclusion criteria, so they are eligible for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9322596065},{"ID":"14029_30-2021_NCT01581463","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypothyroid disease?\nNo, the patient does not have hypothyroid disease. In fact, she has been diagnosed with Hashimoto's thyroiditis, which is an autoimmune disease that can cause hypothyroidism.\n\n#2: Is the patient pregnant?\nNo, the patient is not pregnant.\n\nBased on the inclusion and exclusion criteria provided, the patient would be eligible for the clinical trial.","PROBA":0.90220226},{"ID":"17451_36-2021_NCT04848532","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age criteria?\n\nYes, the patient is between 14 and 18 years old, which meets the age criteria of 14-18 years.\n\n#2: Does the patient meet the BMI criteria?\n\nYes, the patient has a BMI between the 85th and 99th percentiles for sex and age, which meets the BMI criteria.\n\n#3: Does the patient meet the living situation criteria?\n\nYes, the patient is currently living at home with a parent or guardian, which meets the living situation criteria.\n\n#4: Does the patient meet the parent\/guardian criteria?\n\nYes, the patient has at least one parent or guardian who is willing to participate in the study, which meets the parent\/guardian criteria.\n\n#5: Does the patient meet the willingness criteria?\n\nYes, the patient is willing to complete baseline assessment tasks and is willing to download an app to track food intake and complete surveys on the phone for two seven-day periods throughout the course of the study, and is willing to wear a fitness tracker during these same two week-long periods, which meets the willingness criteria.\n\n#6: Does the patient meet the location criteria?\n\nYes, the patient is located in the US and is willing\/able to participate in remote intervention and assessments, which meets the location criteria.\n\n#7: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria.\n\nTherefore, based on the provided information, the patient would be eligible for the clinical trial.","PROBA":0.9544159969},{"ID":"17018_36-2021_NCT01321034","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the inclusion criteria of 18-80 years old. Therefore, the patient meets the age requirement.\n\n#2: LDL Cholesterol\nThe patient's LDL cholesterol is not provided in the patient note. However, since the inclusion criteria require LDL cholesterol to be between 70 and 190 mg\/dL, and the patient's LDL cholesterol is not provided, we cannot determine if the patient meets this criterion.\n\n#3: Triglycerides\nThe patient's triglycerides are not provided in the patient note. However, since the inclusion criteria require triglycerides to be < 500 mg\/dL, and the patient's triglycerides are not provided, we cannot determine if the patient meets this criterion.\n\n#4: Lp(a) Determinations\nThe patient has at least 2 Lp(a) determinations previous to the beginning of the study without differences >20% or > 20 mg\/dL, which meets the inclusion criterion.\n\n#5: No Lipid Lowering Therapy\nThe patient is not on lipid-lowering therapy, which meets the inclusion criterion.\n\n#6: No Active Peptic Ulcer\nThere is no information in the patient note about active peptic ulcer, so we cannot determine if the patient meets this criterion.\n\n#7: No Uncontrolled Diabetes\nThere is no information in the patient note about diabetes or HbA1c, so we cannot determine if the patient meets this criterion.\n\n#8: No Enrolment in Other Drug Clinical Trial\nThere is no information in the patient note about enrolment in other drug clinical trial, so we cannot determine if the patient meets this criterion.\n\nBased on the information provided in the patient note, the patient meets the age requirement and Lp(a) determinations requirement, but does not meet the LDL cholesterol, triglycerides, and diabetes requirements. Therefore, the patient is partially eligible for the clinical trial.","PROBA":0.9455052914},{"ID":"17206_36-2021_NCT02896751","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have sleep apnea?\n\nYes, the patient is complaining of sleep apnea.\n\n#2: Is the patient on stable NIV settings for a minimum of 2 months?\n\nNo, the patient is not on stable NIV settings for a minimum of 2 months.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.900604765},{"ID":"35319_75-2021_NCT00228150","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient male or female?\nThe patient is male.\n\n#3: Is the patient over the age of 35?\nYes, the patient is over the age of 35.\n\n#4: Does the patient have a duration of the disease of less than 3 years since diagnosis?\nYes, the patient has a duration of the disease of less than 3 years since diagnosis.\n\n#5: Is the patient at modified Hoehn and Yahr stage 2.5 or less?\nYes, the patient is at modified Hoehn and Yahr stage 2.5 or less.\n\n#6: Is the patient untreated?\nNo, the patient is not untreated.\n\n#7: Does the patient have any indication of forms of parkinsonism other than PD?\nNo, the patient does not have any indication of forms of parkinsonism other than PD.\n\n#8: Does the patient have severe resting tremor?\nNo, the patient does not have severe resting tremor.\n\n#9: Does the patient have presence of either dyskinesia, fluctuations, or loss of postural reflexes?\nNo, the patient does not have presence of either dyskinesia, fluctuations, or loss of postural reflexes.\n\n#10: Is the patient taking any medications that are exclusion criteria?\nNo, the patient is not taking any medications that are exclusion criteria.\n\n#11: Does the patient have any clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial?\nNo, the patient does not have any clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9622074928},{"ID":"17236_36-2021_NCT03109834","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nBMI: 41.54 (meets criteria)\n\nOne of the following blood lipids: total cholesterol \u2265 200 mg\/dL, LDL-cholesterol \u2265 175 mg\/dL, HDL-cholesterol \u2264 50 mg\/dL, TG 150-400 mg\/dL: Yes, meets criteria\n\nTherefore, the patient meets the inclusion criteria.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9295109398},{"ID":"35503_75-2021_NCT01994343","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the INCLUSION CRITERIA?\n\nYes, the patient is a woman (INCLUSION CRITERIA #1).\n\n#2: Does the patient have a clinical diagnosis of chronic pelvic pain?\n\nYes, the patient is complaining of slowness of movement and tremors, which are symptoms of Parkinson's disease (INCLUSION CRITERIA #2).\n\n#3: Is the patient over the age of 18?\n\nYes, the patient is 55 years old (INCLUSION CRITERIA #3).\n\n#4: Does the patient have non-menstrual or noncyclic pelvic pain?\n\nNo, the patient's symptoms are related to Parkinson's disease and not pelvic pain (EXCLUSION CRITERIA #1).\n\n#5: Has the patient experienced pain for at least 6 months?\n\nYes, the patient has been experiencing symptoms for at least 6 months (INCLUSION CRITERIA #4).\n\nTherefore, the patient does not meet the INCLUSION CRITERIA for the clinical trial. The patient is \"excluded\" from the clinical trial.","PROBA":0.9453469684},{"ID":"17124_36-2021_NCT02364037","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient not desire pregnancy during the next 12 months?\n\nYes, the patient does not desire pregnancy during the next 12 months.\n\n#2: Does the patient desire reversible contraception?\n\nYes, the patient desires reversible contraception.\n\n#3: Is the patient sexually active with a man within the past 6 months or intend to have sex with a man in the next 3 months?\n\nYes, the patient is sexually active with a man within the past 6 months.\n\n#4: Is the patient willing and able to undergo informed consent?\n\nYes, the patient is willing and able to undergo informed consent.\n\n#5: Is the patient not currently pregnant?\n\nYes, the patient is not currently pregnant.\n\n#6: Is the patient a current patient at Family Care Carondelet, Family Care Forest Park Southeast, or Memphis Health Center?\n\nYes, the patient is a current patient at Family Care Carondelet.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9714936445},{"ID":"6901_15-2021_NCT03028181","TOPIC_YEAR":2021,"RESPONSE":"1. Does the patient have acute pancreatitis?\n\nYes, the patient has acute pancreatitis based on the clinical symptoms and laboratory tests (elevation in serum lipase or amylase to three times or greater than the upper limit of normal).\n\n2. Does the patient have other accompanied diseases than acute pancreatitis?\n\nNo, the patient does not have other accompanied diseases than acute pancreatitis.\n\n3. Is the patient a healthy volunteer based on the research conducted by clinicians of primary medical care (control group)?\n\nNo, the patient is not a healthy volunteer based on the research conducted by clinicians of primary medical care (control group) since they have acute pancreatitis.\n\n4. Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria such as alcohol and drugs abusers.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9396597958},{"ID":"35823_75-2021_NCT04796246","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease classified as mild, Hoehn-Yahr Stage I?\n\nYes, the patient's disease is classified as mild, Hoehn-Yahr Stage I.\n\n#3: Is the patient over 18 years old?\n\nYes, the patient is over 18 years old.\n\n#4: Is the patient a resident of the city of Porto Alegre\/RS?\n\nNo, the patient does not meet this criterion.\n\n#5: Is the patient willing to sign an informed consent form?\n\nYes, the patient is willing to sign an informed consent form.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9438741613},{"ID":"35638_75-2021_NCT03300193","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of Essential Tremor or Parkinson's Disease?\n\nYes, the patient has a diagnosis of Parkinson's disease.\n\n#2: Is the patient between 18 and 80 years old?\n\nYes, the patient is 55 years old, which is within the inclusion criteria range.\n\n#3: Did the patient undergo the MRgFUS procedure?\n\nNo, the patient is not eligible for the clinical trial because they have not undergone the MRgFUS procedure.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.91658555},{"ID":"28050_40-2022_NCT04331405","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have acute spinal cord injury?\nNo, the patient does not have acute spinal cord injury.\n\n#2: Is the patient a Russian citizen?\nNo, the patient is not a Russian citizen.\n\n#3: Does the patient have a contusion type of spinal cord injury (MRI-confirmed)?\nYes, the patient has a contusion type of spinal cord injury (MRI-confirmed).\n\n#4: Is the patient's systolic arterial pressure (APsyst) > 185 mmHg OR diastolic AP (APdia) > 105 mmHg OR indications for aggressive AP lowering using i.v. therapy?\nNo, the patient's blood pressure is not within the exclusion criteria.\n\n#5: Does the patient have any of the following: myocardial infarction within 3 months prior to SCI, glucose level < 3.5 mM\/L or > 21 mM\/L, organic CNS pathology, acute internal organs diseases requiring surgical treatment, autoimmune diseases, serious surgical treatment or severe trauma within 3 months prior to SCI, pregnancy or breast feeding, acute infections including tuberculosis, syphilis, HIV, hepatitis B and C etc.?\nNo, the patient does not have any of these conditions.\n\n#6: Does the patient have any rare patient's blood group parameters preventing adequate hUCBMCs sample selection (e.g. Kell+, A2B group, rare phenotype etc.)?\nNo, the patient does not have any rare blood group parameters.\n\n#7: Does the patient have any benign or oncological tumors (if not fully treated prior to SCI)?\nNo, the patient does not have any tumors.\n\n#8: Is the patient unable to participate in key examination following clinic discharge?\nNo, the patient is not unable to participate in key examination following clinic discharge.\n\n#9: Does the patient have any psychiatric diseases preventing patient from informed consent OR treatment plan understanding?\nNo, the patient does not have any psychiatric diseases.\n\n#10: Does the patient have confirmed hypersensitivity and\/or allergy to any component of the studied biological compound?\nNo, the patient does not have any hypersensitivity or allergy to any component of the studied biological compound.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9655858387},{"ID":"33641_71-2021_NCT02142257","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age requirement?\n\nYes, the patient is 34 years old, which is within the age range of 20-60 years.\n\n#2: Does the patient meet the body mass index (BMI) requirement?\n\nYes, the patient's BMI is 41.5, which is above the required threshold of 35.\n\n#3: Does the patient have an eating disorder?\n\nNo, the patient does not have an eating disorder, as this is an exclusion criterion.\n\n#4: Does the patient have severe co-morbidity?\n\nYes, the patient has sleep apnea, polycystic ovary syndrome (PCO), and dissatisfaction with her body shape, which are considered severe co-morbidities.\n\n#5: Has the patient failed to achieve weight loss with lifestyle changes or other conservative approaches?\n\nYes, the patient has tried antiobesity agents and appetite suppressants in the past without success, indicating that she has failed to achieve weight loss with lifestyle changes or other conservative approaches.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9292151996},{"ID":"13968_30-2021_NCT00565864","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 33 years old, which is within the inclusion criteria age range of 20-75 years. Therefore, the patient meets the age criterion.\n\n#2: Primary hypothyroidism\nThe patient has primary hypothyroidism, which is an inclusion criterion.\n\n#3: Stable dose of L-T4 for > 3 months\nThe patient has been on a stable dose of L-T4 for more than 3 months, which is an inclusion criterion.\n\n#4: Documented elevated TSH off L-T4\nThe patient has a documented elevated TSH level while off L-T4, which is an inclusion criterion.\n\n#5: Normal TSH level on usual dose of L-T4\nThe patient has a normal TSH level on their usual dose of L-T4, which is an inclusion criterion.\n\n#6: No acute or chronic medical or psychiatric illnesses that affect thyroid function, mood or cognition\nThe patient does not have any acute or chronic medical or psychiatric illnesses that affect thyroid function, mood or cognition, which is an inclusion criterion.\n\n#7: No medication use that affects thyroid function, mood or cognition (oral contraceptives or estrogen therapy allowed)\nThe patient does not use any medications that affect thyroid function, mood or cognition, except for oral contraceptives or estrogen therapy, which is allowed.\n\n#8: Normal score on screening Mini-Mental State Exam (MMSE)\nThe patient has a normal score on the screening MMSE, which is an inclusion criterion.\n\n#9: Normal vision and hearing\nThe patient has normal vision and hearing, which is an inclusion criterion.\n\n#10: Non-smoker\nThe patient is a non-smoker, which is an inclusion criterion.\n\nTherefore, based on the criteria listed, the patient is eligible for the clinical trial.","PROBA":0.9604506378},{"ID":"6561_15-2021_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of CAD?\n\nYes, the patient has a history of CAD.\n\n#2: Does the patient have a history of non-pancreatic malignancy?\n\nNo, the patient does not have a history of non-pancreatic malignancy.\n\n#3: Does the patient have a prior history of hypersensitivity to interferon alfa-2b?\n\nNo, the patient does not have a prior history of hypersensitivity to interferon alfa-2b.\n\n#4: Does the patient have significant cardiovascular disease?\n\nNo, the patient does not have significant cardiovascular disease.\n\n#5: Is the patient pregnant or breastfeeding?\n\nNo, the patient is not pregnant or breastfeeding.\n\n#6: Does the patient have severe pulmonary disease?\n\nNo, the patient does not have severe pulmonary disease.\n\n#7: Is the patient under the age of 18?\n\nYes, the patient is over the age of 18 and is eligible for the clinical trial.\n\nTherefore, based on the criteria for the clinical trial, the patient would be considered eligible for the study.","PROBA":0.9437401784},{"ID":"5373_12-2021_NCT02361008","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have single IVSD indicated by TTE?\nYes, the patient has single IVSD indicated by TTE.\n\n#2: Does the patient's ventricular septal defects from aortic residual < 3 mm?\nNo, the patient's ventricular septal defects from aortic residual is not < 3 mm.\n\n#3: Is the defect size \u226410 mm?\nNo, the defect size is not \u226410 mm.\n\nBased on the criteria, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9310930835},{"ID":"28018_40-2022_NCT04082143","TOPIC_YEAR":2022,"RESPONSE":"#1: Age\n\nThe patient is 23 years old, which is within the age range of 18-65 years required for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Medical condition\n\nThe patient has prolonged oral bleeding after a tooth extraction, which is related to the medical condition of dental implant therapy. This condition is within the scope of the clinical trial, which aims to evaluate the effectiveness of an allogeneic gum graft during dental implant therapy. Therefore, the patient meets the medical condition inclusion criterion.\n\n#3: Other criteria\n\nThe patient does not have any of the exclusion criteria, such as current smoker, uncontrolled diabetes, or history of radiation in the head and neck region. Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is eligible for the clinical trial.","PROBA":0.9081016412},{"ID":"6654_15-2021_NCT00948142","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have acute bacterial skin-structure infection (ABSSI)?\n\nYes, the patient has acute bacterial skin-structure infection (ABSSI) of no more than 7 days duration, which was suspected or proven to be caused, at least in part, by a gram-positive pathogen.\n\n#2: Does the patient have at least 3 of the following local and\/or systemic symptoms and\/or signs of infection?\n\nYes, the patient has at least 3 of the following local and\/or systemic symptoms and\/or signs of infection: purulent or seropurulent drainage\/discharge, erythema, fluctuance, heat\/localized warmth, pain\/tenderness to palpation, swelling\/induration, regional lymph node swelling or tenderness, temperature >=100.4 degree F, increased white blood cell count, or bandemia.\n\n#3: Has the patient received treatment with another systemic antibiotic for the current ABSSI?\n\nNo, the patient must not have received treatment with another systemic antibiotic for the current ABSSI.\n\nBased on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9645003113},{"ID":"17048_36-2021_NCT01636492","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age requirement?\nThe patient is 32 years old, which is within the age range of 18 to 60 years old, inclusive. Therefore, the patient meets the age requirement.\n\n#2: Does the patient meet the BMI requirement?\nThe patient's BMI is 41.54, which is above the upper limit of 35 kg\/m2. Therefore, the patient does not meet the BMI requirement.\n\n#3: Does the patient meet the other requirements?\nThe patient does not have any clinically significant disease or disorder, and does not have any clinically significant ECG abnormalities. The patient is not positive for hepatitis B, hepatitis C, or HIV infection, and has not had previous treatment with iron for iron deficiency anemia. The patient is not a regular smoker, and does not have a history of alcohol and\/or drug abuse or addiction within the last 2 years. The patient does not have any condition or disease that would render them unsuitable for the study or interfere with their ability to complete the study.\n\nBased on the above, the patient is not eligible for the clinical trial.","PROBA":0.9241264682},{"ID":"16869_36-2021_NCT00172523","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have oligomenorrhea or amenorrhea?\n\nYes, the patient has oligomenorrhea (less than 6 times spontaneous MC per year).\n\n#2: Does the patient have hyperandrogenism?\n\nYes, the patient has hyperandrogenism (either clinical or biochemistry).\n\n#3: Does the patient have PCO by ultrasound?\n\nNo, the patient does not have PCO by ultrasound.\n\n#4: Is the patient after menarche and before menopause?\n\nYes, the patient is after menarche and before menopause.\n\nBased on the criteria, the patient is not eligible for the clinical trial because she does not have PCO by ultrasound.","PROBA":0.9339721777},{"ID":"35814_75-2021_NCT04730245","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient have moderate to severe dyskinesia and\/or motor fluctuations?\nYes, the patient has been experiencing motor fluctuations and has a MDS-UPDRS part IV score equal or higher than 8 following pharmacological adjustments.\n\n#3: Has the patient been on levodopa and other anti-parkinsonian agents?\nYes, the patient has been taking levodopa and other anti-parkinsonian agents.\n\n#4: Is the patient aged 18 years or older?\nYes, the patient is aged 55 years old, which is within the inclusion criteria age range of 18-years old or older.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9209768203},{"ID":"6718_15-2021_NCT01513421","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have an infected intra-abdominal collection requiring a percutaneous drainage?\n\nYes, the patient has an infected intra-abdominal collection (pancreatic adenocarcinoma at the head of pancreas and splenic flecture\/pancreatic tail mass) that requires a percutaneous drainage.\n\n#2: Is the patient over 18 years old?\n\nYes, the patient is over 18 years old.\n\n#3: Is the intra-abdominal collection >5 cm in diameter with signs of infection on imaging?\n\nYes, the intra-abdominal collection is >5 cm in diameter and there are signs of infection on imaging (CT abdomen without contrast showing a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass).\n\nTherefore, based on the inclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.9460583683},{"ID":"6986_15-2021_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 70 years old, which is within the inclusion criteria age range of 70 years or older. Therefore, the patient meets the age inclusion criterion.\n\n#2: Medical condition\nThe patient has a history of CAD and recent abdominal mass with fevers\/rigors and bandemia, which meets the inclusion criteria of emergency admission for acute bacterial infection or presumed acute bacterial infection.\n\n#3: Elective surgery\nThe patient is not undergoing elective surgery, so this exclusion criterion does not apply.\n\n#4: Life expectancy\nThe patient's life expectancy is not less than 30 days, so this exclusion criterion does not apply.\n\nBased on the information provided, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: eligible","PROBA":0.9113916669},{"ID":"14255_30-2021_NCT04263779","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is discharging from a Geisinger hospital (Geisinger Medical Center, Geisinger Wyoming Valley Medical Center, or Geisinger Community Medical Center) and is selected for discharge to a skilled nursing facility (SNF). Yes, the patient meets the inclusion criteria.\n\n#2: Does the patient meet any exclusion criteria?\n\nThe patient does not have a full list of P-SNFs presented to the case manager. Yes, the patient meets the exclusion criteria.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9053580904},{"ID":"28077_40-2022_NCT04553172","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a member of the family, which meets the inclusion criterion.\n\n#2: Does the patient meet any exclusion criteria?\n\nNo, the patient does not meet any exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.8895048243},{"ID":"23681_33-2022_NCT04664478","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a genetic variant in one of the connective tissue target genes?\n\nNo, the patient does not have a genetic variant in one of the connective tissue target genes. Therefore, the patient does not meet the first inclusion criterion.\n\n#2: Is the patient within the age range of 2 to 100 years old?\n\nYes, the patient is within the age range of 2 to 100 years old. Therefore, the patient meets the second inclusion criterion.\n\n#3: Is the patient not pregnant or nursing?\n\nYes, the patient is not pregnant or nursing. Therefore, the patient meets the third exclusion criterion.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the first inclusion criterion.","PROBA":0.9456612642},{"ID":"35383_75-2021_NCT00865111","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a healthy, normal adult man who volunteers to participate?\nNo, the patient is a 55-year-old man with Parkinson's disease, which makes him ineligible for the clinical trial.\n\n#2: Is he 18-45 years of age, inclusive?\nNo, the patient is 55 years old, which is outside the age range of 18-45 years.\n\n#3: Is his BMI between 19 and 30, inclusive?\nNo, the patient's BMI is not provided, so it is unknown if he would be eligible based on this criterion.\n\n#4: Is he considered reliable and capable of understanding his responsibility and role in the study?\nNo, the patient has Parkinson's disease, which may affect his ability to understand and participate in the study.\n\n#5: Has he provided written informed consent?\nNo, the patient's consent is not provided in the information provided.\n\nTherefore, based on the information provided, the patient is ineligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9352347727},{"ID":"30493_65-2021_NCT00703989","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Type 1 diabetes?\nYes, the patient has Type 1 diabetes, so this criterion is met.\n\n#2: Does the patient have a duration of diabetes between zero and fifteen years?\nYes, the patient has had diabetes for seven years, which is within the range of zero to fifteen years.\n\n#3: Is the patient currently receiving insulin therapy?\nYes, the patient is taking 70\/30 Insulin, so this criterion is met.\n\n#4: Are there any exclusion criteria that the patient does not meet?\nNo, the patient does not have any of the exclusion criteria (female, proliferative retinopathy, microalbuminuria, symptomatic diabetic neuropathy, cardiovascular disease, taking medications, or smoking).\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.9318092816},{"ID":"35467_75-2021_NCT01648803","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have probable or definite idiopathic PD (CAPSIT criteria (23))?\n\nYes, the patient has probable or definite idiopathic PD (CAPSIT criteria (23)), so this criterion is met.\n\n#2: Does the patient have one or more of the following PD-associated motor impairments experienced in the week prior to enrollment (based on history and\/or examination): motor fluctuations (end of dose wearing off with hypokinesia and\/or levodopa-induced choreiform dyskinesias), tremor, freezing of gait, or frequent falls (\u2265 1 per week)?\n\nYes, the patient has motor fluctuations (end of dose wearing off with hypokinesia and\/or levodopa-induced choreiform dyskinesias), so this criterion is met.\n\n#3: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria, such as neurological disorders (other than PD) or orthopedic deficits that, in the investigator's judgement, contribute substantially to impaired movement (e.g. stroke with motor sequelae; essential tremor; severe osteoarthritis); cognitive impairment sufficiently severe to interfere with informed consent.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9551367282},{"ID":"35500_75-2021_NCT01991457","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have ALL in complete remission (CR)?\n\nNo, the patient does not have ALL in complete remission (CR). The patient has Parkinson's disease, which is not a type of leukemia. Therefore, the patient is not eligible for this clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.8703571218}]
